<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Medicine/Medical-Specialties/Pediatrics/Journals.html">
<title>Journals RSS : Gourt</title>
<link>http://www.gourt.com/Health/Medicine/Medical-Specialties/Pediatrics/Journals.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2012-02-06T06:24+51:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Journals RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.905v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.832v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.784v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1555v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1501v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1243v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1131v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1093v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1245v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1164v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1158v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1156v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1154v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1135v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1133v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.204v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.203v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.202v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.201v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.200v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.198v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.197v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.189v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.185v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.184v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.183v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.180v1?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.159v2?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/2?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/3?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/6?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/9?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/18?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/28?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/35?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/42?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/49?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/56?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/62?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/68?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/73?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/74?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/82?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/89?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/90?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/91?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/93?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/95?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/97?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/97-a?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/98?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/99?rss=1" />
  <rdf:li rdf:resource="http://archpedi.ama-assn.org/cgi/content/short/166/1/104?rss=1" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00001" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00002" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00003" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00004" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00005" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00006" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00007" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00008" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00009" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00010" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00011" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00012" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00013" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00014" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00015" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00016" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00017" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00018" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00019" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00020" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00021" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00022" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00023" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00024" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00025" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00026" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00027" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00028" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00029" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00030" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00031" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00032" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00033" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00034" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00035" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00036" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00037" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00038" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00039" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00040" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00041" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00042" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00043" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00044" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00045" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00046" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00047" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00048" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00049" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00050" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00051" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00052" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00053" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00054" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00055" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00056" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00057" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00058" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00059" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00060" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00061" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00062" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00063" />
  <rdf:li rdf:resource="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00064" />
  <rdf:li rdf:resource="http://pedsinreview.aappublications.org/cgi/content/full/33/2/e13?rss=1" />
  <rdf:li rdf:resource="http://pedsinreview.aappublications.org/cgi/content/full/33/2/51?rss=1" />
  <rdf:li rdf:resource="http://pedsinreview.aappublications.org/cgi/content/full/33/2/62?rss=1" />
  <rdf:li rdf:resource="http://pedsinreview.aappublications.org/cgi/content/full/33/2/75?rss=1" />
  <rdf:li rdf:resource="http://pedsinreview.aappublications.org/cgi/content/full/33/2/83?rss=1" />
  <rdf:li rdf:resource="http://pedsinreview.aappublications.org/cgi/content/full/33/2/86?rss=1" />
  <rdf:li rdf:resource="http://pedsinreview.aappublications.org/cgi/content/full/33/2/89?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/full/129/2/D1?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X1?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X2?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X3?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X4?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X5?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X6?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X7?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X8?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X9?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X10?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X11?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X12?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X13?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X14?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X15?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X16?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X17?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X18?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X19?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X20?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X21?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X22?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X23?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X24?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X25?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X26?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X27?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X28?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X29?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X30?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X31?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X32?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X33?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X34?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X35?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X36?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X37?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X38?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/full/129/2/201?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/205?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/213?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/222?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/231?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/239?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/248?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e254?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/256?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e262?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/265?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e269?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/275?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e276?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/282?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e285?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/290?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e291?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e298?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/299?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e305?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/309?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e317?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/318?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e325?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/330?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e333?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/338?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e339?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e348?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/349?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/354?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e356?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e364?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/full/129/2/365?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e370?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e377?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/full/129/2/385?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e385?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/387?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e392?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/394?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e414?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e424?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e431?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e438?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e447?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e455?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e460?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e473?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e486?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/full/129/2/e494?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e496?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e504?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e511?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e515?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e519?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e523?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e529?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e535?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e540?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/full/129/2/e561?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e562?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/full/129/2/e567?rss=1" />
  <rdf:li rdf:resource="http://pediatrics.aappublications.org/cgi/content/full/129/2/e568?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.905v1?rss=1">
<title>Environment, Developmental Origins, and Attention-Deficit/Hyperactivity Disorder [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.905v1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.832v1?rss=1">
<title>Recent Progress in Understanding Pediatric Bipolar Disorder [Review Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.832v1?rss=1</link>
<description><![CDATA[
Bipolar disorder is one of the most severe psychiatric illnesses, particularly when onset occurs during childhood or adolescence. With recent empirical evidence, questions regarding the existence of bipolar disorder among children and adolescents have given way to questions regarding prevalence. There are substantial risks inherent in misapplying diagnoses and treatments of bipolar disorder when not warranted and in withholding these diagnoses and treatments when they are warranted. As with adults, the course of bipolar disorder among children and adolescents diagnosed using unmodified diagnostic criteria is characterized by recovery and recurrence, functional impairment, suicidality, and high rates of comorbid psychiatric and medical problems. Discrepancies between increasing billing diagnoses and a stable epidemiologic prevalence of bipolar disorder suggest the possibility that diagnostic criteria are not being systematically applied in some clinical settings. Introducing new diagnoses may exacerbate rather than mitigate concerns regarding misdiagnosis and excessive use of mood-stabilizing medications. Several medications, particularly second-generation antipsychotics, are efficacious for treating acute manic episodes of bipolar I disorder. However, less is known regarding the treatment of other mood states and subtypes of bipolar disorder. Psychosocial treatments provide a forum in which to educate children and families regarding bipolar disorder and its treatment, and may be especially beneficial for reducing depressive symptoms. Offspring of parents with bipolar disorder are at increased risk of developing the illness, as are youth with major depressive disorder and certain psychiatric comorbidities. Preliminary findings regarding biomarkers offer hope that, in the future, these biomarkers may inform diagnostic and treatment decisions.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.784v1?rss=1">
<title>Exposure to Gestational Diabetes Mellitus and Low Socioeconomic Status: Effects on Neurocognitive Development and Risk of Attention-Deficit/Hyperactivity Disorder in Offspring [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.784v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To examine the independent and synergistic effects of gestational diabetes mellitus (GDM) and low socioeconomic status (SES) on neurodevelopment and attention-deficit/hyperactivity disorder (ADHD) outcomes.
Design&nbsp; Cohort study.
Setting&nbsp; Flushing, New York.
Participants&nbsp; A total of 212 preschool children as a part of the ongoing cohort study.
Main Exposures&nbsp; Gestational diabetes mellitus and low SES.
Main Outcome Measures&nbsp; Primary outcomes are ADHD diagnosis based on Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria at age 6 years and several well-validated measures of neurobehavioral outcomes, cognitive functioning, ADHD symptoms, and temperament at age 4 years. Secondary outcomes are parent and teacher reports of behavioral and emotional problems at age 6 years. Neurobehavioral measures in relation to GDM and low SES were examined using generalized estimating equations and multivariate logistic regression analyses.
Results&nbsp; Both maternal GDM and low SES were associated with an approximately 2-fold increased risk for ADHD at age 6 years. However, the risk by GDM was greater among lower SES families than among higher SES families. Children exposed to both GDM and low SES demonstrated compromised neurobehavioral functioning, including lower IQ, poorer language, and impoverished behavioral and emotional functioning. A test of additive interaction found that the risk for ADHD increased over 14-fold (P&nbsp;=&nbsp;.006) when children were exposed to both GDM and low SES. Neither children exposed to maternal GDM alone nor those exposed to low SES alone had a notable increased risk for ADHD.
Conclusions&nbsp; Maternal GDM and low SES, especially in combination, heighten the risk for childhood ADHD. Long-term prevention efforts should be directed at mothers with GDM to avoid suboptimal neurobehavioral development and mitigate the risk for ADHD among their offspring.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1555v1?rss=1">
<title>When Will Routine Testing for Human Immunodeficiency Virus Infection Be the Routine for Adolescents? [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1555v1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1501v1?rss=1">
<title>Hospitalizations for Intussusception Before and After the Reintroduction of Rotavirus Vaccine in the United States [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1501v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To determine whether hospital discharges for intussusception in children younger than 1 year have changed since the reintroduction of rotavirus vaccine in the United States.
Design&nbsp; Serial cross-sectional analysis.
Setting&nbsp; US hospitals.
Participants&nbsp; Children younger than 1 year with a discharge diagnosis of intussusception identified in the Kids' Inpatient Database, a series of nationally representative data sets of pediatric hospital discharges in the United States with 4 available years prior to vaccine reintroduction (1997, 2000, 2003, and 2006) and 1 year after (2009).
Main Exposures&nbsp; Hospital discharge before vs after rotavirus vaccine reintroduction.
Outcome Measures&nbsp; Total number and rate of hospital discharges for infants younger than 1 year with a diagnosis of intussusception (International Classification of Diseases, Ninth Revision, Clinical Modification code 560.0).
Results&nbsp; From 1997 to 2006, there was no change in the total number of hospital discharges for intussusception, with a small decrease in the rate of intussusception discharges (41.6 [95% CI, 36.7-46.5] to 36.5 [95% CI, 31.7-41.2] per 100&nbsp;000 infants). Based on the trend, the predicted rate of discharges for intussusception in 2009 was 36.0 (95% CI, 30.2-41.8) per 100&nbsp;000 infants. The measured rate of hospital discharges for intussusception in 2009 was 33.3 (95% CI, 29.0-37.6) per 100&nbsp;000 infants.
Conclusion&nbsp; The reintroduction of rotavirus vaccine since 2006 has not resulted in a detectable increase in the number of hospital discharges for intussusception among US infants.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1243v1?rss=1">
<title>How to Fight Whooping Cough? [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1243v1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1131v1?rss=1">
<title>Association Between HIV-Related Risk Behaviors and HIV Testing Among High School Students in the United States, 2009 [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1131v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To identify the human immunodeficiency virus (HIV)&ndash;related risk behaviors associated with HIV testing among US high school students who reported ever having sexual intercourse.
Design&nbsp; Secondary analysis of a cross-sectional study.
Setting&nbsp; The 2009 national Youth Risk Behavior Survey.
Participants&nbsp; A total of 7591 US high school students who reported ever having sexual intercourse.
Main Exposures&nbsp; Risk behaviors related to HIV.
Main Outcome Measure&nbsp; Having ever been tested for HIV.
Results&nbsp; Among the 7591 students who reported ever having sexual intercourse, 22.6% had been tested for HIV. Testing for HIV was most likely to be done among students who had ever injected any illegal drug (41.3%; adjusted odds ratio, 1.70; 95% CI,&nbsp;1.14-2.56), had ever been physically forced to have sexual intercourse (36.2%; adjusted odds ratio, 1.43; 95% CI,&nbsp;1.19 -1.72), did not use a condom the last time they had sexual intercourse (28.7%; adjusted odds ratio, 1.28; 95% CI, 1.08-1.51), and had sexual intercourse with 4 or more persons during their life (34.7%; adjusted odds ratio,&nbsp;2.32; 95% CI,&nbsp;1.98-2.73).
Conclusions&nbsp; Most sexually active students, even among those who reported high-risk behaviors for HIV, have not been tested for HIV. New strategies for increasing HIV testing among the adolescent population, including encouraging routine voluntary HIV testing among those who are sexually active, are needed.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1093v1?rss=1">
<title>Early Impact of the US Tdap Vaccination Program on Pertussis Trends [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1093v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To evaluate the impact of the adolescent Tdap vaccination (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine) program on pertussis trends in the United States.
Design&nbsp; Retrospective analysis of nationally reported pertussis cases, January 1, 1990, through December 31, 2009.
Setting&nbsp; United States.
Participants&nbsp; Confirmed and probable pertussis cases.
Intervention&nbsp; The US Tdap vaccination program.
Main Outcome Measure&nbsp; Rate ratios of reported pertussis incidence (defined as incidence among 11- to 18-year-olds divided by the combined incidence in all other age groups) modeled through segmented regression analysis and age-specific trends in reported pertussis incidence over time.
Results&nbsp; A total of 200&nbsp;401 pertussis cases were reported in the United States from 1990 to 2009. Overall incidence ranged from 1.0 to 8.8 per 100&nbsp;000 persons (1991 and 2004, respectively). Slope coefficients (estimated annual rate of change in rate ratios) from segmented regression showed a steady increase in pertussis incidence among adolescents 11 to 18 years old compared with all other age groups before Tdap introduction (slope&nbsp;=&nbsp;0.22; P&nbsp;&lt;&nbsp;.001), and a steep decreasing trend postintroduction (slope&nbsp;=&nbsp;&ndash;0.48; P&nbsp;&lt;&nbsp;.001) suggesting a direct impact of vaccination among adolescents. Indirect effects of adolescent vaccination were not observed among infants younger than 1 year.
Conclusions&nbsp; Changes in pertussis incidence in the United States from 2005 to 2009 revealed a divergence between 11- to 18-year-olds and other age groups, suggesting that targeted use of Tdap among adolescents reduced disease preferentially in this age group. Increased Tdap coverage in adolescents and adults is needed to realize the full direct and indirect benefits of vaccination.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1245v1?rss=1">
<title>Promoting the Health of Our Youth: Why Physical Activity Policies Are Critical [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1245v1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1164v1?rss=1">
<title>Can We Ensure That Children With Public Insurance Have Access to Necessary, High-quality Pediatric Specialty Care? [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1164v1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1158v1?rss=1">
<title>Academic Medical Centers and Equity in Specialty Care Access for Children [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1158v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To test whether specialty clinics' academic medical center (AMC) affiliation was associated with equity in scheduling appointments for children with public vs private insurance. Academic medical centers are safety-net providers of specialty medical care and it is unknown whether equitable access is afforded by AMCs across insurance conditions.
Design&nbsp; Audit study data were linked to data describing audited clinics.
Setting&nbsp; Specialty clinics serving children residing in Cook County, Illinois.
Participants&nbsp; From January-May 2010, 273 clinics were each called twice.
Main Outcome Measures&nbsp; Logistic regression was used to examine associations between AMC affiliation and discriminatory denials of Medicaid&ndash;Children's Health Insurance Program (CHIP) (ie, nonacceptance of Medicaid-CHIP when accepting commercial insurance), controlling for clinics' specialty type, practice size, neighborhood poverty level, and physicians' credentials. Among clinics that accepted both insurances, linear regression was used to examine the association between wait times (days) for appointments and insurance status, adjusting for covariates. Tests for interaction terms were performed to identify changes in wait time for academic clinics across insurance status.
Results&nbsp; Of the 273 paired calls to clinics, 155 (57%) resulted in discriminatory denials of Medicaid-CHIP. The odds of a discriminatory denial were 45% lower if a clinic was AMC affiliated (odds ratio, 0.55; 95% CI, 0.31-0.99). On average, academic clinics scheduled Medicaid-CHIP appointments with wait times 40 days longer than private insurance (&beta;, 40.73; 95% CI, 5.06-76.41).
Conclusions&nbsp; Affiliation with an AMC was associated with fewer discriminatory denials of children with Medicaid-CHIP. However, children with Medicaid-CHIP had significantly longer wait times at AMC-affiliated clinics compared with privately insured children. Academic medical centers' propensity toward serving publicly insured patients makes them candidates for targeted resource allocation, perhaps with incentives contingent on equitable appointment acceptance and wait times.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1156v1?rss=1">
<title>Prevalence of Clinically Important Traumatic Brain Injuries in Children With Minor Blunt Head Trauma and Isolated Severe Injury Mechanisms [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1156v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To determine the prevalence of clinically important traumatic brain injuries (TBIs) with severe injury mechanisms in children with minor blunt head trauma but with no other risk factors from the Pediatric Emergency Care Applied Research Network (PECARN) TBI prediction rules (defined as isolated severe injury mechanisms).
Design&nbsp; Secondary analysis of a large prospective observational cohort study.
Setting&nbsp; Twenty-five emergency departments participating in the PECARN.
Patients&nbsp; Children with minor blunt head trauma and Glasgow Coma Scale scores of at least 14.
Intervention&nbsp; Treating clinicians completed a structured data form that included injury mechanism (severity categories defined a priori).
Main Outcome Measures&nbsp; Clinically important TBIs were defined as intracranial injuries resulting in death, neurosurgical intervention, intubation for more than 24 hours, or hospital admission for at least 2 nights. We investigated the rate of clinically important TBIs in children with either severe injury mechanisms or isolated severe injury mechanisms.
Results&nbsp; Of the 42&nbsp;412 patients enrolled in the overall study, 42&nbsp;099 (99%) had injury mechanisms recorded, and their data were included for analysis. Of all study patients, 5869 (14%) had severe injury mechanisms, and 3302 (8%) had isolated severe injury mechanisms. Overall, 367 children had clinically important TBIs (0.9%; 95% CI, 0.8%-1.0%). Of the 1327 children younger than 2 years with isolated severe injury mechanisms, 4 (0.3%; 95% CI, 0.1%-0.8%) had clinically important TBIs, as did 12 of the 1975 children 2 years or older (0.6%; 95% CI, 0.3%-1.1%).
Conclusion&nbsp; Children with isolated severe injury mechanisms are at low risk of clinically important TBI, and many do not require emergent neuroimaging.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1154v1?rss=1">
<title>Medical Home Access and Health Care Use and Expenditures Among Children With Special Health Care Needs [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1154v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To test associations between having a medical home and health services use and expenditures among US children with special health care needs (CSHCN).
Design&nbsp; Cross-sectional analysis.
Setting&nbsp; The 2003-2008 Medical Expenditure Panel Surveys.
Participants&nbsp; A total of 9816 CSHCN up to 17 years, including 1056 with a functional or sensory limitation and 8760 without a limitation.
Main Exposure&nbsp; Parent or caregiver report of CSHCN having a medical home.
Main Outcome Measures&nbsp; We examined CSHCN's annual use of outpatient, inpatient, emergency department, and dental visits, and annual outpatient, inpatient, emergency department, prescription medication, dental, and other health care expenditures.
Results&nbsp; CSHCN with a medical home had 14% more dental visits compared with CSHCN without a medical home (incidence rate ratio [IRR], 1.14; 95% CI, 1.03-1.25); this finding is significant for CSHCN without limitations but not for those with limitations. The medical home was associated with greater odds of incurring total, outpatient, prescription medication, and dental expenditures (odds ratio range, 1.25-1.92). Among CSHCN with a limitation, children with a medical home had lower annual inpatient expenditures compared with those without a medical home (mean, &ndash;$968; 95% CI, &ndash;$121 to &ndash;$1928), and among CSHCN without a limitation, children with a medical home had higher annual prescription medication expenditures compared with those without a medical home (mean, $87; 95% CI, $22-$153).
Conclusions&nbsp; There were few differences in annual health services use and expenditures between CSHCN with and without a medical home. However, the medical home may be associated with lower inpatient expenditures and higher prescription medication expenditures within subgroups of CSHCN.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1135v1?rss=1">
<title>Parental Recall of Doctor Communication of Weight Status: National Trends From 1999 Through 2008 [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1135v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To examine time trends in parental reports of health professional notification of childhood overweight over the last decade and to determine the characteristics most associated with such notification.
Design&nbsp; Secondary data analysis using 2 tests to examine the relationships between multiple factors on the reports of parents and/or caregivers (hereinafter "parents") and logistic regression for multivariate analysis.
Setting&nbsp; National Health and Nutrition Examination Survey, 1999 through 2008.
Participants&nbsp; Parents of 4985 children aged 2 to 15 years with body mass index (BMI) in the 85th percentile or higher based on measured height and weight.
Main Outcome Measures&nbsp; Affirmative answer to the following question: "Has a doctor or health professional ever told you that your child is overweight?"
Results&nbsp; During 1999 through 2008, 22% of parents of children with BMIs in the 85th percentile or higher reported having been told by a doctor or health professional that their child was overweight; recall of notification was actually more likely among nonwhite and poor children. This percentage increased from 19.4% to 23.2% from the 1999-2004 period and further accelerated in the 2007-2008 period to 29.1%. The time trend persisted in multivariate analyses, with significantly more parents reporting having been told in 2007 through 2008 than in 1999 through 2000.
Conclusion&nbsp; Fewer than one-quarter of parents of overweight children report having been told that their child was overweight. While reports of notification have increased over the last decade (perhaps because of [1] revised definitions of overweight and obesity, [2] increased concern about children with BMIs in the 85th to 95th sex- and age-specific percentiles, or [3] improved recall by parents), further research is necessary to determine where and why communication of weight status breaks down.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1133v1?rss=1">
<title>The Impact of State Laws and District Policies on Physical Education and Recess Practices in a Nationally Representative Sample of US Public Elementary Schools [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.1133v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To examine the impact of state- and school district&ndash;level policies on the prevalence of physical education (PE) and recess in a nationally representative sample of US public elementary schools.
Design&nbsp; Analyses from annual, nationally representative, cross-sectional surveys of school administrators in the United States.
Setting&nbsp; Data were collected through surveys conducted between February and June during the 2006-2007 through 2008-2009 school years. State laws and district policies were compiled annually by researchers at the University of Illinois at Chicago using established legal research techniques.
Participants&nbsp; The sample size was 47 states, 690 districts, and 1761 schools.
Main Exposures&nbsp; State- and school district&ndash;level PE and recess-related laws
Main Outcome Measures&nbsp; Twenty minutes of daily recess and 150 min/wk of PE.
Results&nbsp; The odds of schools having 150 min/wk of PE increased if they were located in states (odds ratio [OR], 2.8; 95% CI, 1.3-5.7) or school districts (OR, 2.4; 95% CI, 1.3-4.3) having a law or policy requiring 150 min/wk of PE. Schools located in states with laws encouraging daily recess were significantly more likely to have 20 minutes of recess daily (OR, 1.8; 95% CI, 1.2-2.8). District policies were not significantly associated with school-level recess practices. Adequate PE time was inversely associated with recess and vice versa, suggesting that schools are substituting one form of physical activity for another rather than providing the recommended amount of both recess and PE.
Conclusion&nbsp; By mandating PE or recess, policy makers can effectively increase school-based physical activity opportunities for youth.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.204v1?rss=1">
<title>Evaluation of the Web-Based Computer-Tailored FATaintPHAT Intervention to Promote Energy Balance Among Adolescents: Results From a School Cluster Randomized Trial [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.204v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To evaluate the short- and long-term results of FATaintPHAT, a Web-based computer-tailored intervention aiming to increase physical activity, decrease sedentary behavior, and promote healthy eating to contribute to the prevention of excessive weight gain among adolescents.
Design&nbsp; Cluster randomized trial with an intervention group and a no-intervention control group.
Setting&nbsp; Twenty schools in the Netherlands.
Participants&nbsp; A total of 883 students (aged 12-13 years).
Intervention&nbsp; The FATaintPHAT (VETisnietVET in Dutch) Web-based computer-tailored intervention.
Outcome Measures&nbsp; Self-reported behaviors (diet, physical activity, sedentary behavior) and pedometer counts were measured at baseline and at 4-month and 2-year follow-up; body mass index (BMI), waist circumference, and fitness were measured at baseline and at 2-year follow-up. Descriptive and multilevel regression analyses were conducted among the total study population and among students not meeting behavioral recommendations at baseline (students at risk).
Results&nbsp; The complete case analyses showed that FATaintPHAT had no effect on BMI and waist circumference. However, the intervention was associated with lower odds (0.54) of drinking more than 400 mL of sugar-sweetened beverages per day and with lower snack intake (&beta;&nbsp;=&nbsp;&ndash;0.81 snacks/d) and higher vegetable intake (&beta;&nbsp;=&nbsp;19.3 g/d) but also with a lower step count (&beta;&nbsp;=&nbsp;&ndash;10&nbsp;856 steps/wk) at 4-month follow-up. In addition, among students at risk, FATaintPHAT had a positive effect on fruit consumption (&beta;&nbsp;=&nbsp;0.39 g/d) at 4-month follow-up and on step count (&beta;&nbsp;=&nbsp;14&nbsp;228 steps/wk) at 2-year follow-up but an inverse effect on the odds of sports participation (odds ratio, 0.45) at 4-month follow-up. No effects were found for sedentary behavior.
Conclusion&nbsp; The FATaintPHAT intervention was associated with positive short-term effects on diet but with no effects or unfavorable effects on physical activity and sedentary behavior.
Trial Registration&nbsp; Netherlands Trial Registry:  ISRCTN15743786
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.203v1?rss=1">
<title>Iron in Infancy and Long-term Development [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.203v1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.202v1?rss=1">
<title>The Challenge of Mental Health Care in Pediatrics [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.202v1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.201v1?rss=1">
<title>Doctor-Office Collaborative Care for Pediatric Behavioral Problems: A Preliminary Clinical Trial [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.201v1?rss=1</link>
<description><![CDATA[
Objectives&nbsp; To evaluate the feasibility and clinical benefits of an integrated mental health intervention (doctor-office collaborative care [DOCC]) vs enhanced usual care (EUC) for children with behavioral problems.
Design&nbsp; Cases were assigned to DOCC and EUC using a 2:1 randomization schedule that resulted in 55 DOCC and 23 EUC cases.
Setting&nbsp; Preassessment was conducted in 4 pediatric primary care practices. Postassessment was conducted in the pediatric or research office. Doctor-office collaborative care was provided in the practice; EUC was initiated in the office but involved a facilitated referral to a local mental health specialist.
Participants&nbsp; Of 125 referrals (age range, 5-12 years), 78 children participated.
Interventions&nbsp; Children and their parents were assigned to receive DOCC or EUC.
Main Outcome Measures&nbsp; Preassessment diagnostic status was evaluated using the Schedule for Affective Disorders and Schizophrenia for School-aged Children. Preassessment and 6-month postassessment ratings of behavioral and emotional problems were collected from parents using the Vanderbilt Attention-Deficit/Hyperactivity Disorder Diagnostic Parent Rating Scale, as well as individualized goal achievement ratings forms. At discharge, care managers and a diagnostic evaluator completed the Clinical Global Impression Scale, and pediatricians and parents completed satisfaction and study feedback measures.
Results&nbsp; Group comparisons found significant improvements for DOCC over EUC in service use and completion, behavioral and emotional problems, individualized behavioral goals, and overall clinical response. Pediatricians and parents were highly satisfied with DOCC.
Conclusion&nbsp; The feasibility and clinical benefits of DOCC for behavioral problems support the integration of collaborative mental health services for common mental disorders in primary care.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.200v1?rss=1">
<title>Banning All Sugar-Sweetened Beverages in Middle Schools: Reduction of In-School Access and Purchasing but Not Overall Consumption [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.200v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To determine whether state policies that regulate beverages in schools are associated with reduced in-school access and purchase of sugar-sweetened beverages (SSBs) and reduced consumption of SSBs (in and out of school) among adolescents.
Design&nbsp; Cross-sectional.
Setting&nbsp; Public schools in 40 states.
Participants&nbsp; Students sampled in fifth and eighth grades (spring 2004 and 2007, respectively).
Main Exposures&nbsp; State policies that ban all SSBs and state policies that ban only soda for 2006-2007.
Main Outcome Measures&nbsp; In-school SSB access, in-school SSB purchasing behavior, and overall SSB consumption (in and out of school) in eighth grade.
Results&nbsp; The proportions of eighth-grade students who reported in-school SSB access and purchasing were similar in states that banned only soda (66.6% and 28.9%, respectively) compared with states with no beverage policy (66.6% and 26.0%, respectively). In states that banned all SSBs, fewer students reported in-school SSB access (prevalence difference, &ndash;14.9; 95% CI, &ndash;23.6 to &ndash;6.1) or purchasing (&ndash;7.3; &ndash;11.0 to &ndash;3.5), adjusted for race/ethnicity, poverty status, locale, state obesity prevalence, and state clustering. Results were similar among students who reported access or purchasing SSBs in fifth grade compared with those who did not. Overall SSB consumption was not associated with state policy; in each policy category, approximately 85% of students reported consuming SSBs at least once in the past 7 days. Supplementary analyses indicated that overall consumption had only a modest association with in-school SSB access.
Conclusion&nbsp; State policies that ban all SSBs in middle schools appear to reduce in-school access and purchasing of SSBs but do not reduce overall consumption.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.198v1?rss=1">
<title>A Randomized Trial of Single Home Nursing Visits vs Office-Based Care After Nursery/Maternity Discharge: The Nurses for Infants Through Teaching and Assessment After the Nursery (NITTANY) Study [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.198v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To compare office-based care (OBC) with a care model using a home nursing visit (HNV) as the initial postdischarge encounter for "well" breastfeeding newborns and mothers.
Design&nbsp; Randomized controlled trial.
Setting&nbsp; A single academic hospital.
Participants&nbsp; A total of 1154 postpartum mothers intending to breastfeed and their 1169 newborns of at least 34 weeks' gestation.
Interventions&nbsp; Home nursing visits were scheduled no later than 2 days after discharge; OBC timing was physician determined.
Outcome Measures&nbsp; Mothers completed telephone surveys at 2 weeks, 2 months, and 6 months. The primary outcome was unplanned health care utilization for mothers and newborns within 2 weeks of delivery. Other newborn outcomes were proportion seen within 2 days after discharge and breastfeeding duration. Maternal mental health, parenting competence, and satisfaction with care outcomes were assessed. Analyses followed an intent-to-treat paradigm.
Results&nbsp; At 2 weeks, hospital readmissions and emergency department visits were uncommon, and there were no study group differences in these outcomes or with unplanned outpatient visit frequency. Newborns in the HNV group were seen no more than 2 days after discharge more commonly than those in the OBC group (85.9% vs 78.8%) (P&nbsp;=&nbsp;.002) and were more likely to be breastfeeding at 2 weeks (92.3% vs 88.6%) (P&nbsp;=&nbsp;.04) and 2 months (72.1% vs 66.4%) (P&nbsp;=&nbsp;.05) but not 6 months. No group differences were detected for maternal mental health or satisfaction with care, but HNV group mothers had a greater parenting sense of competence (P&nbsp;&lt;&nbsp;.01 at 2 weeks and 2 months).
Conclusions&nbsp; Home nursing visits are a safe and effective alternative to OBC for the initial outpatient encounter after maternity/nursery discharge with similar patterns of unplanned health care utilization and modest breastfeeding and parenting benefits.
Trial Registration&nbsp; clinicaltrials.gov Identifier: NCT00360204
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.197v1?rss=1">
<title>Iron-Fortified vs Low-Iron Infant Formula: Developmental Outcome at 10 Years [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.197v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To assess long-term developmental outcome in children who received iron-fortified or low-iron formula.
Design&nbsp; Follow-up at 10 years of a randomized controlled trial (1991-1994) of 2 levels of formula iron. Examiners were masked to group assignment.
Setting&nbsp; Urban areas around Santiago, Chile.
Participants&nbsp; The original study enrolled healthy, full-term infants in community clinics; 835 completed the trial. At 10 years, 473 were assessed (56.6%).
Intervention&nbsp; Iron-fortified (mean, 12.7 mg/L) or low-iron (mean, 2.3 mg/L) formula from 6 to 12 months.
Main Outcome Measures&nbsp; We measured IQ, spatial memory, arithmetic achievement, visual-motor integration, visual perception, and motor functioning. We used covaried regression to compare iron-fortified and low-iron groups and considered hemoglobin level before randomization and sensitivity analyses to identify 6-month hemoglobin levels at which groups diverged in outcome.
Results&nbsp; Compared with the low-iron group, the iron-fortified group scored lower on every 10-year outcome (significant for spatial memory and visual-motor integration; suggestive for IQ, arithmetic achievement, visual perception, and motor coordination; 1.4-4.6 points lower; effect sizes, 0.13-0.21). Children with high 6-month hemoglobin levels (>12.8 g/dL [to convert to grams per liter, multiply by 10]) showed poorer outcome on these measures if they received iron-fortified formula (10.7-19.3 points lower; large effect sizes, 0.85-1.36); those with low hemoglobin levels (&lt;10.5 g/dL) showed better outcome (2.6-4.5 points higher; small but significant effects, 0.22-0.36). High hemoglobin levels represented 5.5% of the sample (n&nbsp;=&nbsp;26) and low hemoglobin levels represented 18.4% (n&nbsp;=&nbsp;87).
Conclusion&nbsp; Long-term development may be adversely affected in infants with high hemoglobin levels who receive 12.7 mg/L of iron-fortified formula. Optimal amounts of iron in infant formula warrant further study.
Trial Registration&nbsp; clinicaltrials.gov Identifier: NCT01166451
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.189v1?rss=1">
<title>Effects of a Family Intervention in Reducing HIV Risk Behaviors Among High-Risk Hispanic Adolescents: A Randomized Controlled Trial [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.189v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To determine the efficacy of a family intervention in reducing human immunodeficiency virus (HIV) risk behaviors among Hispanic delinquent adolescents.
Design&nbsp; Randomized controlled trial.
Setting&nbsp; Miami&ndash;Dade County Public School System and Miami&ndash;Dade County's Department of Juvenile Services, Florida.
Participants&nbsp; A total of 242 Hispanic delinquent youth aged 12 to 17 years and their primary caregivers completed outcome assessments at baseline and 3 months after intervention.
Intervention&nbsp; Participants were randomized to either Familias Unidas (120 participants), a Hispanic-specific, family intervention designed to reduce HIV risk behaviors among Hispanic youth, or a community practice control condition (122 participants).
Main Outcome Measures&nbsp; Self-reported measures included unprotected sexual behavior, engaging in sex while under the influence of alcohol and/or drugs, number of sexual partners, and incidence of sexually transmitted diseases. Family functioning (eg, parent-adolescent communication, positive parenting, and parental monitoring) was also assessed via self-report measures.
Results&nbsp; Compared with community practice, Familias Unidas was efficacious in increasing condom use during vaginal and anal sex during the past 90 days, reducing the number of days adolescents were under the influence of drugs or alcohol and had sex without a condom, reducing sexual partners, and preventing unprotected anal sex at the last sexual intercourse. Familias Unidas was also efficacious, relative to community practice, in increasing family functioning and most notably in increasing parent-adolescent communication and positive parenting.
Conclusion&nbsp; These results suggest that culturally tailored, family-centered prevention interventions may be appropriate and efficacious in reducing HIV risk behaviors among Hispanic delinquent adolescents.
Trial Registration&nbsp; clinicaltrials.gov Identifier: NCT01257022
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.185v1?rss=1">
<title>Reduced Risks of Neural Tube Defects and Orofacial Clefts With Higher Diet Quality [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.185v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To examine whether better maternal diet quality was associated with reduced risk for selected birth defects.
Design&nbsp; A multicenter, population-based case-control study, the National Birth Defects Prevention Study.
Setting&nbsp; Ten participating centers in the United States.
Participants&nbsp; Eligible subjects' estimated due dates were from October 1997 through December 2005. Telephone interviews were conducted with 72% of case and 67% of control mothers. Analyses included 936 cases with neural tube defects (NTDs), 2475 with orofacial clefts, and 6147 nonmalformed controls.
Main Exposures&nbsp; Food-frequency data were used to calculate the Mediterranean Diet Score (MDS) and Diet Quality Index (DQI), modeled after existing indices.
Main Outcome Measure&nbsp; Adjusted odds ratios (ORs).
Results&nbsp; After covariate adjustment, increasing diet quality based on either index was associated with reduced risks for the birth defects studied. The strongest association was between anencephaly and DQI; the OR for highest vs lowest quartile was 0.49 (95% CI, 0.31-0.75). The ORs for cleft lip with or without cleft palate and cleft palate and DQI were also notable (0.66 [95% CI, 0.54-0.81] and 0.74 [95%CI, 0.56-0.96], respectively).
Conclusions&nbsp; Healthier maternal dietary patterns, as measured by diet quality scores, were associated with reduced risks of NTDs and clefts. These results suggest that dietary approaches could lead to further reduction in risks of major birth defects and complement existing efforts to fortify foods and encourage periconceptional multivitamin use.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.184v1?rss=1">
<title>The Importance of Food [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.184v1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.183v1?rss=1">
<title>Sustained Decreases in Risk Exposure and Youth Problem Behaviors After Installation of the Communities That Care Prevention System in a Randomized Trial [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.183v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To test whether the Communities That Care (CTC) prevention system reduced levels of risk and adolescent problem behaviors community-wide 6 years after installation of CTC and 1 year after study-provided resources ended.
Design&nbsp; A community randomized trial.
Setting&nbsp; Twenty-four small towns in 7 states, matched within state, randomly assigned to control or intervention condition in 2003.
Participants&nbsp; A panel of 4407 fifth-grade students was surveyed annually through 10th grade from 2004 to 2009.
Intervention&nbsp; A coalition of community stakeholders received training and technical assistance to install CTC, used epidemiologic data to identify elevated risk factors and depressed protective factors in the community, and implemented programs to address their community's elevated risks from a menu of tested and effective programs for youths aged 10 to 14 years, their families, and schools.
Outcome Measures&nbsp; Levels of risk and incidence and prevalence of tobacco, alcohol, and other drug use; delinquency; and violent behavior by grade 10.
Results&nbsp; Mean levels of targeted risks increased less rapidly between grades 5 and 10 in CTC than in control communities and were significantly lower in CTC than control communities in grade 10. The incidence of delinquent behavior, alcohol use, and cigarette use and the prevalence of current cigarette use and past-year delinquent and violent behavior were significantly lower in CTC than in control communities in grade 10.
Conclusions&nbsp; Using the CTC system can produce enduring reductions in community-wide levels of risk factors and problem behaviors among adolescents beyond the years of supported implementation, potentially contributing to long-term public health benefits.
Trial Registration&nbsp; clinicaltrials.gov Identifier: NCT01088542
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.180v1?rss=1">
<title>Associations Between Displayed Alcohol References on Facebook and Problem Drinking Among College Students [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.180v1?rss=1</link>
<description><![CDATA[
Objective&nbsp; To examine the associations between displayed alcohol use and intoxication/problem drinking (I/PD) references on Facebook and self-reported problem drinking using a clinical scale.
Design&nbsp; Content analysis and cross-sectional survey.
Setting&nbsp; Facebook Web site (http://www.facebook.com/).
Participants&nbsp; The study included undergraduate students (age range, 18-20 years) at 2 state universities with public Facebook profiles.
Main Exposures&nbsp; The profiles were categorized into 1 of 3 distinct categories: Nondisplayers, Alcohol Displayers, and I/PD Displayers.
Outcome Measures&nbsp; An online survey measured problem drinking using the Alcohol Use Disorders Identification Test (AUDIT) scale. Analyses examined associations between alcohol display category and (1) AUDIT problem drinking category using logistic regression, (2) AUDIT score using negative binomial regression, and (3) alcohol-related injury using the Fisher exact test.
Results&nbsp; Among 307 profiles identified, 224 participants completed the survey (73% response rate). The average age was 18.8 years; 122 (54%) were female; 152 (68%) were white; and approximately 50% were from each university. Profile owners who displayed I/PD were more likely (odds ratio, 4.4; 95% CI, 2.0-9.4) to score in the problem drinking category of the AUDIT scale, had 64.0% (incidence rate ratio, 1.64; 95% CI, 1.27-11.0) higher AUDIT scores overall, and were more likely to report an alcohol-related injury in the past year (P&nbsp;=&nbsp;.002).
Conclusions&nbsp; Displayed references to I/PD were positively associated with AUDIT scores suggesting problem drinking as well as alcohol-related injury. Results suggest that clinical criteria for problem drinking can be applied to Facebook alcohol references.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.159v2?rss=1">
<title>Excess Body Mass Index-Years, a Measure of Degree and Duration of Excess Weight, and Risk for Incident Diabetes [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/archpediatrics.2011.159v2?rss=1</link>
<description><![CDATA[
Objective&nbsp; To evaluate the relation between excess body mass index (BMI)&ndash;years, a measure of the degree to which an individual's BMI (calculated as weight in kilograms divided by height in meters squared) exceeds the reference BMI and the duration for which he or she carries excess BMI, and incident diabetes.
Design&nbsp; Longitudinal analysis.
Setting&nbsp; United States of America.
Participants&nbsp; A total of 8157 adolescents and young adults aged 14 to 21 years at the start of the National Longitudinal Survey of Youth 1979 with self-reported measures of height, weight, and diabetes status (type unspecified) from 1981 through 2006.
Main Exposure&nbsp; Excess BMI-years, which were calculated by subtracting the actual BMI from the reference BMI (25.0 for adults or 85th percentile for adolescents) for each study year and cumulating excess BMI for the study duration.
Main Outcome Measure&nbsp; We conducted logistic regression models to predict presumed type 2 diabetes (after excluding presumed type 1 diabetes) as a function of age, sex, race, excess BMI-years, and specific interactions.
Results&nbsp; A higher level of excess BMI-years was associated with an increased risk of diabetes. For example, on average, white men aged 40 years with 200 excess BMI-years had 2.94 times (95% confidence interval, 2.36-3.67) higher odds of developing diabetes compared with men of the same age and race with 100 excess BMI-years. For a given level of excess BMI-years, younger compared with older and Hispanic and black compared with white individuals had higher risk of developing diabetes. Our study is limited by use of self-reported data without specification of diabetes type.
Conclusions&nbsp; Because younger compared with older individuals have a higher risk of self-reported diabetes for a given level of excess BMI-years and cumulative exposure to excess BMI is increasing among younger US birth cohorts, public health interventions should target younger adults.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/2?rss=1">
<title>Climbing team descending the Nisqually Glacier, Mount Rainier National Park, Washington, June 5th, 2010 [About the Cover]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/2?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/3?rss=1">
<title>About This Journal [About This Journal]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/3?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/6?rss=1">
<title>This Month in Archives of Pediatrics &#x26; Adolescent Medicine [This Month in Archives of Pediatrics &#x26; Adolescent Medicine]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/6?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/9?rss=1">
<title>Prevalence of Polypharmacy Exposure Among Hospitalized Children in the United States [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/9?rss=1</link>
<description><![CDATA[
Objective&nbsp; To assess the prevalence and patterns of exposure to drugs and therapeutic agents among hospitalized pediatric patients.
Design&nbsp; Retrospective cohort study.
Setting&nbsp; A total of 411 general hospitals and 52 children's hospitals throughout the United States.
Patients&nbsp; A total of 587&nbsp;427 patients younger than 18 years, excluding healthy newborns, hospitalized in 2006, representing one-fifth of all pediatric admissions in the United States.
Main Outcome Measures&nbsp; Daily and cumulative exposure to drugs and therapeutic agents.
Results&nbsp; The most common exposures varied by patient age and by hospital type, with acetaminophen, albuterol, various antibiotics, fentanyl, heparin, ibuprofen, morphine, ondansetron, propofol, and ranitidine being among the most prevalent exposures. A considerable fraction of patients were exposed to numerous medications: in children's hospitals, on the first day of hospitalization, patients younger than 1 year at the 90th percentile of daily exposure to distinct medications received 11 drugs, and patients 1 year or older received 13 drugs; in general hospitals, 8 and 12 drugs, respectively. By hospital day 7, in children's hospitals, patients younger than 1 year at the 90th percentile of cumulative exposure to distinct distinct medications had received 29 drugs, and patients 1 year or older had received 35; in general hospitals, 22 and 28 drugs, respectively. Patients with less common conditions were more likely to be exposed to more drugs (P&nbsp;=&nbsp;.001).
Conclusion&nbsp; A large fraction of hospitalized pediatric patients are exposed to substantial polypharmacy, especially patients with rare conditions.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/18?rss=1">
<title>Parental Smoking and the Risk of Middle Ear Disease in Children: A Systematic Review and Meta-analysis [Review Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/18?rss=1</link>
<description><![CDATA[
Objective&nbsp; A systematic review and meta-analysis of studies of the association between secondhand tobacco smoke (SHTS) and middle ear disease (MED) in children.
Data Sources&nbsp; MEDLINE, EMBASE, and CAB abstracts (through December 2010) and reference lists.
Study Selection&nbsp; Sixty-one epidemiological studies of children assessing the effect of SHTS on outcomes of MED. Articles were reviewed, and the data were extracted and synthesized by 2 researchers.
Main Outcome Exposures&nbsp; Children's SHTS exposure.
Main Outcome Measures&nbsp; Middle ear disease in children.
Results&nbsp; Living with a smoker was associated with an increased risk of MED in children by an odds ratio (OR) of 1.62 (95% CI, 1.33-1.97) for maternal postnatal smoking and by 1.37 (95% CI, 1.25-1.50) for any household member smoking. Prenatal maternal smoking (OR, 1.11; 95% CI, 0.93-1.31) and paternal smoking (OR, 1.24; 95% CI, 0.98-1.57) were associated with a nonsignificant increase in the risk of MED. The strongest effect was on the risk of surgery for MED, where maternal postnatal smoking increased the risk by an OR of 1.86 (95% CI, 1.31-2.63) and paternal smoking by 1.83 (95% CI, 1.61-2.07).
Conclusions&nbsp; Exposure to SHTS, particularly to smoking by the mother, significantly increases the risk of MED in childhood; this risk is particularly strong for MED requiring surgery. We have shown that per year 130&nbsp;200 of child MED episodes in the United Kingdom and 292&nbsp;950 of child frequent ear infections in the United States are directly attributable to SHTS exposure in the home.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/28?rss=1">
<title>Effect of Pediatric Bilateral Cochlear Implantation on Language Development [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/28?rss=1</link>
<description><![CDATA[
Objective&nbsp; To examine spoken language outcomes in children undergoing bilateral cochlear implantation compared with matched peers undergoing unilateral implantation.
Design&nbsp; Case-control, frequency-matched, retrospective cross-sectional multicenter study.
Setting&nbsp; Two Belgian and 3 Dutch cochlear implantation centers.
Participants&nbsp; Twenty-five children with 1 cochlear implant matched with 25 children with 2 cochlear implants selected from a retrospective sample of 288 children who underwent cochlear implantation before 5 years of age.
Intervention&nbsp; Cochlear implantation.
Main Outcome Measures&nbsp; Performance on measures of spoken language comprehension and expression (Reynell Developmental Language Scales and Schlichting Expressive Language Test).
Results&nbsp; On the receptive language tests (mean difference [95% CI], 9.4 [0.3-18.6]) and expressive language tests (15.7 [5.9-25.4] and 9.7 [1.5-17.9]), children undergoing bilateral implantation performed significantly better than those undergoing unilateral implantation. Because the 2 groups were matched with great care on 10 auditory, child, and environmental factors, the difference in performance can be mainly attributed to the bilateral implantation. A shorter interval between both implantations was related to higher standard scores. Children undergoing 2 simultaneous cochlear implantations performed better on the expressive Word Development Test than did children undergoing 2 sequential cochlear implantations.
Conclusions&nbsp; The use of bilateral cochlear implants is associated with better spoken language learning. The interval between the first and second implantation correlates negatively with language scores. On expressive language development, we find an advantage for simultaneous compared with sequential implantation.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/35?rss=1">
<title>Cochlear Implantation in Prelingually Deafened Adolescents [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/35?rss=1</link>
<description><![CDATA[
Objectives&nbsp; To determine the efficacy of cochlear implantation (CI) in prelingually deafened adolescent children and to evaluate predictive variables for successful outcomes.
Design&nbsp; Retrospective medical record review.
Participants&nbsp; Children aged 10 to 17 years with prelingual hearing loss (mean length of deafness, 11.5 years) who received a unilateral CI (mean age at CI, 12.9 years).
Intervention&nbsp; Unilateral CI.
Main Outcome Measures&nbsp; Standard speech perception testing (Consonant-Nucleus-Consonant [CNC] monosyllabic word test and Hearing in Noise [HINT] sentence test) was performed preoperatively, 1 year postoperatively (year 1), and at the last follow-up/end of the study (EOS).
Results&nbsp; There was a highly significant improvement in speech perception scores for both HINT sentence and CNC word testing from the preoperative testing to year 1 (mean change score, 51.10% and 32.23%, respectively; P&nbsp;&lt;&nbsp;.001) and from the preoperative testing to EOS (mean change score, 60.02% and 38.73%, respectively; P&nbsp;&lt;&nbsp;.001), with a significantly greater increase during the first year (P&nbsp;&lt;&nbsp;.001). In addition, there was a highly significant correlation between improvements in performance scores on the CNC word and HINT sentence speech perception tests and both age at CI and length of deafness at the year 1 testing (P&nbsp;&le;.009) but not from the year 1 testing to EOS testing. Adolescents with progressive deafness and those using oral communication before CI performed significantly better than age-matched peers.
Conclusions&nbsp; Adolescents with prelingual deafness undergoing unilateral CI show significant improvement in objective hearing outcome measures. Patients with shorter lengths of deafness and earlier age at CI tend to outperform their peers. In addition, patients with progressive deafness and those using oral communication have significantly better objective outcomes than their peers.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/42?rss=1">
<title>Excess Body Mass Index-Years, a Measure of Degree and Duration of Excess Weight, and Risk for Incident Diabetes [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/42?rss=1</link>
<description><![CDATA[
Objective&nbsp; To evaluate the relation between excess body mass index (BMI)&ndash;years, a measure of the degree to which an individual's BMI (calculated as weight in kilograms divided by height in meters squared) exceeds the reference BMI and the duration for which he or she carries excess BMI, and incident diabetes.
Design&nbsp; Longitudinal analysis.
Setting&nbsp; United States of America.
Participants&nbsp; A total of 8157 adolescents and young adults aged 14 to 21 years at the start of the National Longitudinal Survey of Youth 1979 with self-reported measures of height, weight, and diabetes status (type unspecified) from 1981 through 2006.
Main Exposure&nbsp; Excess BMI-years, which were calculated by subtracting the actual BMI from the reference BMI (25.0 for adults or 85th percentile for adolescents) for each study year and cumulating excess BMI for the study duration.
Main Outcome Measure&nbsp; We conducted logistic regression models to predict presumed type 2 diabetes (after excluding presumed type 1 diabetes) as a function of age, sex, race, excess BMI-years, and specific interactions.
Results&nbsp; A higher level of excess BMI-years was associated with an increased risk of diabetes. For example, on average, white men aged 40 years with 200 excess BMI-years had 2.94 times (95% confidence interval, 2.36-3.67) higher odds of developing diabetes compared with men of the same age and race with 100 excess BMI-years. For a given level of excess BMI-years, younger compared with older and Hispanic and black compared with white individuals had higher risk of developing diabetes. Our study is limited by use of self-reported data without specification of diabetes type.
Conclusions&nbsp; Because younger compared with older individuals have a higher risk of self-reported diabetes for a given level of excess BMI-years and cumulative exposure to excess BMI is increasing among younger US birth cohorts, public health interventions should target younger adults.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/49?rss=1">
<title>Physical Activity and Performance at School: A Systematic Review of the Literature Including a Methodological Quality Assessment [Review Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/49?rss=1</link>
<description><![CDATA[
Objective&nbsp; To describe the prospective relationship between physical activity and academic performance.
Data Sources&nbsp; Prospective studies were identified from searches in PubMed, PsycINFO, Cochrane Central, and Sportdiscus from 1990 through 2010.
Study Selection&nbsp; We screened the titles and abstracts for eligibility, rated the methodological quality of the studies, and extracted data.
Main Exposure&nbsp; Studies had to report at least 1 physical activity or physical fitness measurement during childhood or adolescence.
Main Outcome Measures&nbsp; Studies had to report at least 1 academic performance or cognition measure during childhood or adolescence.
Results&nbsp; We identified 10 observational and 4 intervention studies. The quality score of the studies ranged from 22% to 75%. Two studies were scored as high quality. Methodological quality scores were particularly low for the reliability and validity of the measurement instruments. Based on the results of the best-evidence synthesis, we found evidence of a significant longitudinal positive relationship between physical activity and academic performance.
Conclusions&nbsp; Participation in physical activity is positively related to academic performance in children. Because we found only 2 high-quality studies, future high-quality studies are needed to confirm our findings. These studies should thoroughly examine the dose-response relationship between physical activity and academic performance as well as explanatory mechanisms for this relationship.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/56?rss=1">
<title>Association of Exclusive Breastfeeding Duration and Fibrinogen Levels in Childhood and Adolescence: The European Youth Heart Study [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/56?rss=1</link>
<description><![CDATA[
Objective&nbsp; To examine the association of exclusive breastfeeding (BF) duration on serum fibrinogen levels of children and adolescents from Estonia and Sweden, controlling for other potential confounding factors that could mediate in this relationship.
Design&nbsp; Cross-sectional study.
Setting&nbsp; Estonia and Sweden.
Participants&nbsp; A total of 704 children (mean [SD] age, 9.5 [0.4] years) and 665 adolescents (15.5 [0.5] years).
Main Exposure&nbsp; Exclusive BF duration was reported by the mother and categorized in the following 5 categories: never, less than 1 month, 1 to 3 months, more than 3 to 6 months, and more than 6 months.
Main Outcome Measures&nbsp; Fasting fibrinogen level. Age, sex, pubertal status, country, adiposity (sum of 5 skin-fold thicknesses), total cholesterol and triglyceride levels, blood pressure, physical activity (accelerometry), birth weight, maternal education, body mass index, and age were considered confounders in the analyses.
Results&nbsp; Longer duration of exclusive BF was associated with lower fibrinogen levels regardless of confounders (P&nbsp;&lt;&nbsp;.001). Mean (SD) fibrinogen levels were lower in youth who were breastfed for more than 3 months (after adjusting for all confounders, P&nbsp;&lt;&nbsp;.01) in children (2.55 [0.04] vs 2.77 [0.03] g/L), adolescents (2.59 [0.06] vs 2.72 [0.03] g/L), boys (2.47 [0.04] vs 2.73 [0.04] g/L), and girls (2.60 [0.03] vs 2.75 [0.02] g/L), compared with groups who were not breastfed. The results did not change substantially after further adjustment for birth weight and maternal educational level.
Conclusions&nbsp; Exclusive BF is associated with less low-grade inflammation, as estimated by serum fibrinogen levels, in healthy children and adolescents. These findings give further support to the notion that early feeding patterns could program cardiovascular disease risk factors later in life.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/62?rss=1">
<title>Child Health Providers&#x27; Precautionary Discussion of Emotions During Communication About Results of Newborn Genetic Screening [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/62?rss=1</link>
<description><![CDATA[
Objective&nbsp; To demonstrate a quantitative abstraction method for Communication Quality Assurance projects to assess physicians' communication about hidden emotions after newborn genetic screening.
Design&nbsp; Communication quality indicator analysis.
Setting&nbsp; Standardized parent encounters performed in practicing physicians' clinics or during educational workshops for residents.
Participants&nbsp; Fifty-nine pediatrics residents, 53 pediatricians, and 31 family physicians.
Intervention&nbsp; Participants were asked to counsel standardized parents about a screening result; counseling was recorded, transcribed, and parsed into statements (each with 1 subject and 1 predicate). Pairs of abstractors independently compared statements with a data dictionary containing explicit-criteria definitions.
Outcome Measures&nbsp; Four groups of "precautionary empathy" behaviors (assessment of emotion, anticipation/validation of emotion, instruction about emotion, and caution about future emotion), with definitions developed for both "definite" and "partial" instances.
Results&nbsp; Only 38 of 143 transcripts (26.6%) met definite criteria for at least 1 of the precautionary empathy behaviors. When partial criteria were counted, this number increased to 80 of 143 transcripts (55.9%). The most common type of precautionary empathy was the "instruction about emotion" behavior (eg, "don't be worried"), which may sometimes be leading or premature.
Conclusions&nbsp; Precautionary empathy behaviors were rare in this analysis. Further study is needed, but this study should raise concerns about the quality of communication services after newborn screening.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/68?rss=1">
<title>The Interplay of Outpatient Services and Psychiatric Hospitalization Among Medicaid-Enrolled Children With Autism Spectrum Disorders [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/68?rss=1</link>
<description><![CDATA[
Objective&nbsp; To examine whether increased provision of community-based services is associated with decreased psychiatric hospitalizations among children with autism spectrum disorders (ASDs).
Design&nbsp; Retrospective cohort study using discrete-time logistic regression to examine the association of service use in the preceding 60 days with the risk of hospitalization.
Setting&nbsp; The Medicaid-reimbursed health care system in the continental United States.
Participants&nbsp; Medicaid-enrolled children with an ASD diagnosis in 2004 (N&nbsp;=&nbsp;28&nbsp;428).
Main Exposures&nbsp; Use of respite care and therapeutic services, based on procedure codes.
Main Outcome Measures&nbsp; Hospitalizations associated with a diagnosis of ASD (International Classification of Diseases, 10th Revision, codes 299.0, 299.8, and 299.9).
Results&nbsp; Each $1000 increase in spending on respite care during the preceding 60 days resulted in an 8% decrease in the odds of hospitalization in adjusted analysis. Use of therapeutic services was not associated with reduced risk of hospitalization.
Conclusions&nbsp; Respite care is not universally available through Medicaid. It may represent a critical type of service for supporting families in addressing challenging child behaviors. States should increase the availability of respite care for Medicaid-enrolled children with ASDs. The lack of association between therapeutic services and hospitalization raises concerns regarding the effectiveness of these services.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/73?rss=1">
<title>Incorrect Data in Table 3 and in Text in: Effect of Neuromuscular Warm-up on Injuries in Female Soccer and Basketball Athletes in Urban Public High Schools: Cluster Randomized Controlled Trial [Correction]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/73?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/74?rss=1">
<title>Health-Related Quality of Life in Pediatric Minor Injury: Reliability, Validity, and Responsiveness of the Pediatric Quality of Life Inventory in the Emergency Department [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/74?rss=1</link>
<description><![CDATA[
Objective&nbsp; To evaluate the feasibility, reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL) in the first 2 weeks after pediatric emergency department care of minor injury.
Design&nbsp; Prospective cohort study.
Setting&nbsp; Pediatric hospital emergency department.
Participants&nbsp; Children and adolescents with minor injury (n&nbsp;=&nbsp;334).
Main Outcome Measures&nbsp; Child- and parent-reported clinical outcomes and PedsQL scale scores.
Results&nbsp; The PedsQL had good to excellent internal consistency reliability (&alpha; range, 0.73-0.93). For each day that the clinical symptoms persisted, there were consistent decreases in mean health-related quality of life (HRQOL) scores (validity testing). There were significantly greater negative changes in mean HRQOL scores for fractures vs soft-tissue injuries and for lower vs upper extremity injuries. Clinical outcomes categorized as poor had large negative changes in HRQOL not seen in good outcome groups. Distribution-based indicators of change supported good responsiveness (effect sizes for the physical summary score, 0.01-2.44; group differences at follow-up exceeded estimates of the minimal importance difference).
Conclusions&nbsp; The PedsQL is feasible, reliable, and demonstrates good construct and discriminant validity and responsiveness in measuring short-term outcome after minor injury care in the pediatric emergency department. Assessing short-term outcome from the patient perspective with HRQOL measures may greatly enhance our ability to evaluate the effectiveness of emergency department care.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/82?rss=1">
<title>Adolescent Perceptions of Risk and Need for Safer Sexual Behaviors After First Human Papillomavirus Vaccination [Article]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/82?rss=1</link>
<description><![CDATA[
Objectives&nbsp; To (1) examine perceptions of risk of human papillomavirus (HPV) and other sexually transmitted infections (STIs), (2) examine perceived need for safer sexual behaviors, and (3) determine factors associated with less perceived need for safer sexual behaviors, all in the context of receiving the first HPV vaccination.
Design&nbsp; Cross-sectional baseline analysis from an ongoing longitudinal cohort study.
Setting&nbsp; An urban hospital-based adolescent primary care clinic.
Participants&nbsp; Girls 13 to 21 years (for this article girls are defined as being aged 13 to 21 years) (n&nbsp;=&nbsp;339) receiving their first HPV vaccination and their mothers (n&nbsp;=&nbsp;235).
Main Outcome Measures&nbsp; (1) Girls' perceived risk of HPV after HPV vaccination, (2) girls' perceived risk of other STIs after vaccination, (3) girls' perceived need for continued safer sexual behaviors after vaccination, and (4) factors associated with girls' perception of less need for safer sexual behaviors.
Results&nbsp; Mean age of girls was 16.8 years. Most participants (76.4%) were black, and 57.5% were sexually experienced. Girls perceived themselves to be at less risk for HPV than for other STIs after HPV vaccination (P&nbsp;&lt;&nbsp;.001). Although most girls reported continued need for safer sexual behaviors, factors independently associated with perception of less need for safer sexual behaviors included adolescent factors (lower HPV and HPV vaccine knowledge and less concern about HPV) and maternal factors (lower HPV and HPV vaccine knowledge, physician as a source of HPV vaccine information, and lack of maternal communication about the HPV vaccine).
Conclusions&nbsp; Few adolescents perceived less need for safer sexual behaviors after the first HPV vaccination. Education about HPV vaccines and encouraging communication between girls and their mothers may prevent misperceptions among these adolescents.
]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/89?rss=1">
<title>Picture of the Month--Quiz Case [Special Feature]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/89?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/90?rss=1">
<title>Picture of the Month--Diagnosis [Special Feature]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/90?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/91?rss=1">
<title>Pediatric Polypharmacy: Time to Lock the Medicine Cabinet? [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/91?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/93?rss=1">
<title>Cochlear Implants in Children and Adolescents [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/93?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/95?rss=1">
<title>Communicating With Parents About Newborn Screening: The Skill of Eliciting Unspoken Emotions [Editorial]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/95?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/97?rss=1">
<title>Exposure to Magnetic Fields During Pregnancy and Asthma in Offspring [The Pediatric Forum]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/97?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/97-a?rss=1">
<title>Observations on Power-Line Magnetic Fields Associated With Asthma in Children [The Pediatric Forum]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/97-a?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/98?rss=1">
<title>Observations on Power-Line Magnetic Fields Associated With Asthma in Children--Reply [The Pediatric Forum]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/98?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/99?rss=1">
<title>Error in Byline in: National School Lunch Program for All [Correction]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/99?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://archpedi.ama-assn.org/cgi/content/short/166/1/104?rss=1">
<title>Parental Smoking and Childhood Ear Infections: A Dangerous Combination [Advice for Patients]</title>
<link>http://archpedi.ama-assn.org/cgi/content/short/166/1/104?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00001">
<title>Mechanism of onset and exacerbation of chronic glomerulonephritis and its treatment</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00001</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00002">
<title>Type of milk feeding affects hematological parameters and serum lipid profile in Japanese infants</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00002</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00003">
<title>Age- and gender-specific reference intervals for serum lipid levels (measured with an Advia 1650 analyzer) in school children</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00003</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00004">
<title>Development of the Affordances in the Home Environment for Motor DevelopmentInfant Scale</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00004</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00005">
<title>Parental overweight/obesity, social factors, and child overweight/obesity at 7 years of age</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00005</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00006">
<title>Predictors of growth in children based on 2007 Korean national growth charts</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00006</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00007">
<title>Vitamin D deficiency among healthy infants and toddlers: A prospective study from Irbid, Jordan</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00007</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00008">
<title>Economic burden of injuries in children: Cohort study based on administrative data in a northwestern Italian region</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00008</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00009">
<title>Effects of maternal smoking during pregnancy on body composition in offspring</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00009</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00010">
<title>Atypical social development in neonatal intensive care unit survivors at 12 months</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00010</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00011">
<title>Clinical and molecular microbiological characteristics of carbapenem-resistant iAcinetobacter baumannii/i strains in an NICU</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00011</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00012">
<title>Ampicillin versus penicillin in the empiric therapy of extremely low-birthweight neonates at risk of early onset sepsis</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00012</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00013">
<title>Time-course effect of a single dose of hydrocortisone for refractory hypotension in preterm infants</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00013</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00014">
<title>Meconium-related ileus in extremely low-birthweight neonates: Etiological considerations from histology and radiology</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00014</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00015">
<title>Management of perianal abscess with ihainosankyuto/i in neonates and young infants</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00015</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00016">
<title>Vitamin K prophylaxis and late vitamin K deficiency bleeding in infants: Fifth nationwide survey in Japan</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00016</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00017">
<title>Clinical practice guidelines for children with cancer presenting with fever to the emergency room</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00017</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00018">
<title>Elevated serum interleukin-7 level in idiopathic steroid-sensitive nephrotic syndrome</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00018</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00019">
<title>Serum KL-6 and surfactant protein D in children with 2009 pandemic H1N1 influenza infection</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00019</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00020">
<title>Risk factors for bronchopulmonary dysplasia in neonates born at 1500g (19992009)</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00020</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00021">
<title>Neonatal lactic acidosis with methylmalonic aciduria due to novel mutations in the iSUCLG1/i gene</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00021</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00022">
<title>Early weight changes after birth and serum high-molecular-weight adiponectin level in preterm infants</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00022</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00023">
<title>Neonatal correlates of adverse outcomes in very low-birthweight infants in the NICU Network</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00023</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00024">
<title>Alkaline phosphatase as an early marker of hemolysis in newborns</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00024</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00025">
<title>Increase of child car seat temperature in cars parked in the outpatient parking lot</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00025</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00026">
<title>Language assessment of non-handicapped twins at 5 years of age</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00026</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00027">
<title>Variations in early gross motor milestones and in the age of walking in Japanese children</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00027</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00028">
<title>Validity and reliability of physical activity questionnaire for Japanese students</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00028</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00029">
<title>Primary headache: Role of investigations in a cohort of young children and adolescents</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00029</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00030">
<title>Frequency of vitamin D insufficiency in healthy children between 1 and 16 years of age in Turkey</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00030</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00031">
<title>Pulse steroids as induction therapy for children with ulcerative colitis</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00031</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00032">
<title>Non-invasive assessment of liver fibrosis in patients after the Fontan operation</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00032</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00033">
<title>Tyrosinemia type 1 in Spain: Mutational analysis, treatment and long-term outcome</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00033</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00034">
<title>Phenotypic and mutation spectrums of Thai patients with isovaleric acidemia</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00034</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00035">
<title>Cognitive P300-evoked potentials in school-age children after surgical or transcatheter intervention for ventricular septal defect</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00035</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00036">
<title>Telecommunication system for children undergoing stem cell transplantation</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00036</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00037">
<title>Multiplex polymerase chain reaction for six herpesviruses after hematopoietic stem cell transplantation</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00037</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00038">
<title>Individualized long-term enzyme therapy for Gaucher disease type 1 in Slovenia</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00038</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00039">
<title>Vitamin Bsub12/sub treatment reduces mononuclear DNA damage</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00039</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00040">
<title>Maternal and fetal circulation of unusual bile acids: A pilot study</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00040</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00041">
<title>Early onset of neonatal listeriosis</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00041</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00042">
<title>Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00042</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00043">
<title>Correlation between transient tachypnea of the newborn and wheezing attack</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00043</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00044">
<title>Outcomes of very-low-birthweight infants at 3 years of age born in 20032004 in Japan</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00044</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00045">
<title>Congenital heart disease in a Chinese hospital: pre- and postnatal detection, incidence, clinical characteristics and outcomes</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00045</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00046">
<title>Persistent left superior vena cava: Experience of a tertiary health-care center</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00046</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00047">
<title>Infantile acute promyelocytic leukemia without an RAR rearrangement</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00047</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00048">
<title>An infant with life-threatening hemangioma successfully treated with low-dose cyclophosphamide</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00048</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00049">
<title>Natural alteration of antibody titers in a patient with immunoglobulin A deficiency after chickenpox over a 10-year period</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00049</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00050">
<title>Non-alcoholic steatohepatitis caused by malnutrition after pediatric liver transplantation</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00050</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00051">
<title>Direct hyperbilirubinemia caused by severe subgaleal hemorrhage with ischemic liver injury</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00051</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00052">
<title>Unexplained late-onset hemolysis and methemoglobinemia in a preterm infant</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00052</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00053">
<title>Arthritis associated with Kawasaki disease: MRI findings and serum matrix metalloproteinase-3 profiles</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00053</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00054">
<title>Giant heart tumors in infants leading to sudden, unexpected death: Description of two cases</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00054</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00055">
<title>Efficacy of inchinkoto for a patient with liver fibrosis complicated with transient abnormal myelopoiesis in Down&#x27;s syndrome</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00055</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00056">
<title>Viral load and rapid diagnostic test in patients with pandemic H1N1 2009</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00056</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00057">
<title>Bilobar atelectasis as clinical presentation of iMycoplasma pneumoniae/i infection</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00057</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00058">
<title>Onset of meningoencephalitis: Disseminated candidiasis</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00058</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00059">
<title>Brain abscess due to iStreptococcus intermedius/i in a 3-year-old child</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00059</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00060">
<title>Parageusia in an epileptic child treated with lamotrigine</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00060</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00061">
<title>Paraneoplastic pemphigus with Castleman&#x27;s disease and bronchiolitis obliterans</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00061</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00062">
<title>Breast pseudoangiomatous stromal hyperplasia during early childhood</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00062</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00063">
<title>Acknowledgments</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00063</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00064">
<title>Announcements</title>
<link>http://www.ingentaconnect.com/content/bsc/ped/2011/00000053/00000006/art00064</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pedsinreview.aappublications.org/cgi/content/full/33/2/e13?rss=1">
<title>Ethics for the Pediatrician: A Brave New Pediatrics? Managing the Desire for Better Children Through Biotechnological Enhancement</title>
<link>http://pedsinreview.aappublications.org/cgi/content/full/33/2/e13?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pedsinreview.aappublications.org/cgi/content/full/33/2/51?rss=1">
<title>Childhood Antecedents to Adult Cardiovascular Disease</title>
<link>http://pedsinreview.aappublications.org/cgi/content/full/33/2/51?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pedsinreview.aappublications.org/cgi/content/full/33/2/62?rss=1">
<title>Pediatric Systemic Lupus Erythematosus: More Than a Positive Antinuclear Antibody</title>
<link>http://pedsinreview.aappublications.org/cgi/content/full/33/2/62?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pedsinreview.aappublications.org/cgi/content/full/33/2/75?rss=1">
<title>Consultation with the Specialist: Thyroid Nodules</title>
<link>http://pedsinreview.aappublications.org/cgi/content/full/33/2/75?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pedsinreview.aappublications.org/cgi/content/full/33/2/83?rss=1">
<title>Complementary, Holistic, and Integrative Medicine: Crohn Disease</title>
<link>http://pedsinreview.aappublications.org/cgi/content/full/33/2/83?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pedsinreview.aappublications.org/cgi/content/full/33/2/86?rss=1">
<title>An Infant Who Has Dome-Shaped Papules</title>
<link>http://pedsinreview.aappublications.org/cgi/content/full/33/2/86?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pedsinreview.aappublications.org/cgi/content/full/33/2/89?rss=1">
<title>Index of Suspicion * Case 1: Lymphadenopathy, Prolonged Hematuria, Proteinuria, and Weight Loss in a Teenage Boy * Case 2: Red, Swollen, Painful Eye in a 12-year-old Boy With Methylmalonic Acidemia * Case 3: Ptosis and Diplopia After a Respiratory Infection in a 7-year-old Girl</title>
<link>http://pedsinreview.aappublications.org/cgi/content/full/33/2/89?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/full/129/2/D1?rss=1">
<title>Pediatrics Digest</title>
<link>http://pediatrics.aappublications.org/cgi/content/full/129/2/D1?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X1?rss=1">
<title>Drinking Frequency as a Brief Screen for Adolescent Alcohol Problems</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X1?rss=1</link>
<description><![CDATA[
The American Academy of Pediatrics recommends routine alcohol screening for all adolescents. Problem-based substance use screens for adolescents exist, but have limitations. A consumption-based alcohol screen could provide an empirically validated, very brief method to screen youth for alcohol-related problems.
National sample data indicate that frequency of alcohol use has high sensitivity and specificity in identifying youth with alcohol-related problems. A range of age-specific frequency cut scores perform well; specific cut points can be selected based on the screening context. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X2?rss=1">
<title>Hepatitis A Vaccination Coverage Among Adolescents in the United States</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X2?rss=1</link>
<description><![CDATA[
Hepatitis A infection causes severe disease among adolescents and adults. Hepatitis A vaccination (HepA) is recommended universally at 1 year, with vaccination through 18 years based on risk or desire for protection.
This is the first study to evaluate adolescent HepA coverage in the United States using provider-reported vaccination data. HepA coverage was low among adolescents, leaving a large population susceptible to hepatitis A infection maturing into adulthood. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X3?rss=1">
<title>Cardiac Screening Prior to Stimulant Treatment of ADHD: A Survey of US-Based Pediatricians</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X3?rss=1</link>
<description><![CDATA[
Over the past decade, drug oversight committees and professional organizations have debated the evidence regarding cardiac screening to identify undiagnosed disorders associated with sudden cardiac death in youth with attention-deficit/hyperactivity disorder before beginning treatment with stimulants.
How practicing pediatricians have responded to this controversy is not known. We present results from a national sample of pediatricians regarding current attitudes, barriers, and practices for cardiac screening in youth with attention-deficit/hyperactivity disorder before prescribing stimulants. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X4?rss=1">
<title>Public Attitudes Regarding the Use of Residual Newborn Screening Specimens for Research</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X4?rss=1</link>
<description><![CDATA[
The retention and use of residual bloodspots is a practice of many state newborn screening programs. This practice has become controversial, and little is known about public attitudes on the retention and research use of newborn residual bloodspots.
This study offers a detailed analysis of public attitudes regarding bloodspot retention and use for biomedical research. The results also offer insights on how education regarding this practice influences support for newborn screening and residual bloodspot use. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X5?rss=1">
<title>Citizens&#x27; Values Regarding Research With Stored Samples From Newborn Screening in Canada</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X5?rss=1</link>
<description><![CDATA[
Newborn screening (NBS) programs may store bloodspot samples and use them for secondary purposes, such as research. Recent public controversies and lawsuits over storage and secondary uses underscore the need to engage the public on these issues.
This public engagement study identifies values underlying citizens&rsquo; acceptance of and discomfort with research from NBS samples. Well-designed methods of public education and civic discourse on the risks and benefits of storage and secondary uses of NBS samples are required. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X6?rss=1">
<title>The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and Adolescents</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X6?rss=1</link>
<description><![CDATA[
Studies on vaccine safety are crucial to the ongoing success of our national immunization program. ITP has a known association with MMR in young children, occurring in 1 in 40 000 doses. The risk after other childhood vaccines is unknown.
This study found no increased risk of ITP after vaccines other than MMR in young children, confirmed an association of ITP with MMR, and also found that ITP may occur after certain other vaccines in older children. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X7?rss=1">
<title>A National Profile of Childhood Epilepsy and Seizure Disorder</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X7?rss=1</link>
<description><![CDATA[
Epilepsy/seizure disorder is known to be associated with a range of mental health and neurodevelopmental comorbidities, based on clinical studies, and on population studies largely conducted outside the United States.
In a nationally representative sample of US children, estimated prevalence of reported lifetime epilepsy/seizure disorder was 1%, and of current epilepsy/seizure disorder was 6.3/1000. Developmental, mental health, and physical comorbidities are common, warranting enhanced surveillance, and an integrated service approach. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X8?rss=1">
<title>Societal Values and Policies May Curtail Preschool Children&#x27;s Physical Activity in Child Care Centers</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X8?rss=1</link>
<description><![CDATA[
Three-fourths of US preschool-age children are in child care; many are not achieving recommended levels of physical activity. Daily physical activity is essential for motor and socioemotional development and for the prevention of obesity. Little is known about physical-activity barriers in child care.
Injury and school-readiness concerns may inhibit children&rsquo;s physical activity in child care. Fixed playground equipment that meets licensing codes is unchallenging and uninteresting to children. Centers may cut time and space for gross motor play to address concerns about school readiness. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X9?rss=1">
<title>Trends in US Pediatric Drowning Hospitalizations, 1993-2008</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X9?rss=1</link>
<description><![CDATA[
In the United States, drowning is the second leading cause of unintentional injury death among children (1&ndash;19), accounting for &gt;1000 deaths per year. Total lifetime costs in 2000 were estimated to be $2.6 billion for children aged 0 to 14.
National trends in pediatric drowning hospitalizations by age and gender have not been reported. This study provides benchmarks that can be used for state and regional comparisons and monitoring of injury prevention efforts. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X10?rss=1">
<title>Value of Follow-up Examinations of Children and Adolescents Evaluated for Sexual Abuse and Assault</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X10?rss=1</link>
<description><![CDATA[
Although follow-up examinations are recommended for suspected victims of sexual abuse or assault, little is known about the potential benefits of a second examination with regard to diagnosing trauma or sexually transmitted infections.
In ~23% of pediatric patients evaluated for sexual abuse or assault, a second examination by a specialist changed the interpretation of trauma likelihood or results in the detection of a sexually transmitted infection. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X11?rss=1">
<title>Carpooling and Booster Seats: A National Survey of Parents</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X11?rss=1</link>
<description><![CDATA[
Booster seat use improves seat belt fit and reduces risk of injury for children &lt;57 in tall. Booster seat use decreases between ages 4 and 8 years. Children observed riding with other children frequently do not use booster seats.
In this national survey of parents, we found that a majority of parents of 4- to 8-year-old children carpool, and when they carpool booster seat use is inconsistent. Social norms and self-efficacy appear to influence booster seat use when carpooling. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X12?rss=1">
<title>Oral Sucrose and &#x22;Facilitated Tucking&#x22; for Repeated Pain Relief in Preterms: A Randomized Controlled Trial</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X12?rss=1</link>
<description><![CDATA[
Preterm infants are exposed to inadequately managed painful procedures during their NICU stay, which can lead to altered pain responses. Nonpharmacologic approaches are established for the treatment of single painful procedures, but evidence for their effectiveness across time is lacking.
Oral sucrose with or without the added technique of facilitated tucking has a pain-relieving effect even in extremely premature infants undergoing repeated pain exposures; facilitated tucking alone seems to be less effective for repeated pain exposures over time. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X13?rss=1">
<title>Prospective Study of Sunburn and Sun Behavior Patterns During Adolescence</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X13?rss=1</link>
<description><![CDATA[
Childhood UV light exposures, specifically sunburns, have been shown to be associated with melanoma development later in life.
To date, most studies in this age group have been cross sectional in nature. This is the first prospective study of sunburn and sun behaviors in this age group. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X14?rss=1">
<title>Predictors of Cognitive Function and Recovery 10 Years After Traumatic Brain Injury in Young Children</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X14?rss=1</link>
<description><![CDATA[
Previous research has demonstrated that young children with traumatic brain injury are at elevated risk of poor outcomes, particularly following severe injuries. These deficits persist until at least 5 years postinsult. Factors predicting outcomes in this age group have not been established.
This study follows survivors of very early traumatic brain injury into adolescence. Results indicate that severe injury is associated with poorest outcome, but after 3 years, the gap between children with severe traumatic brain injury and peers stabilizes. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X15?rss=1">
<title>Intellectual, Behavioral, and Social Outcomes of Accidental Traumatic Brain Injury in Early Childhood</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X15?rss=1</link>
<description><![CDATA[
Traumatic brain injury in school-aged children is associated with intellectual, behavioral, and social deficits. Research into outcomes of children injured before 3 years of age is limited despite data suggesting a high incidence of injury in this age group.
Results show that a moderate to severe traumatic brain injury before 3 years of age is associated with lowered cognitive function. Furthermore, this study highlights the link between social disadvantage and poor outcomes after traumatic brain injury in early childhood. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X16?rss=1">
<title>Randomized Trial of Oral Versus Sequential IV/Oral Antibiotic for Acute Pyelonephritis in Children</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X16?rss=1</link>
<description><![CDATA[
The standard initial management for infants and children with acute pyelonephritis is intravenous antibiotic treatment.
Our results support the use of an oral cefixime treatment of initial episodes of acute pyelonephritis involving a gram-negative bacteria strain in children aged 1 month to 3 years who are without urological abnormalities and without clinical hemodynamic impairment. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X17?rss=1">
<title>Prevalence, Patterns, and Persistence of Sleep Problems in the First 3 Years of Life</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X17?rss=1</link>
<description><![CDATA[
Sleep problems are common during childhood, but screening for sleep problems in the clinic setting is often cursory. Moreover, there are few longitudinal studies examining the prevalence and persistence of sleep problems in young children.
Patterns of sleep problems vary across early development, but sleep problems arising in infancy persist in 21% of children through 36 months of age. Parent response to a nonspecific query about sleep problems may overlook relevant sleep symptoms and behaviors. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X18?rss=1">
<title>RCT of Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X18?rss=1</link>
<description><![CDATA[
Upper respiratory tract infections (URIs) are very common in children. Currently, there are no effective preventive measures for URI. There are no studies on the effect of montelukast for prevention of URI.
In a randomized, double-blind, placebo-controlled study of preschool-aged children, 12-week prophylactic treatment with montelukast did not reduce the incidence of URI. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X19?rss=1">
<title>Late Intravenous Immunoglobulin Treatment in Patients With Kawasaki Disease</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X19?rss=1</link>
<description><![CDATA[
The effectiveness of intravenous immunoglobulin treatment of patients with Kawasaki disease within 9 days of illness has been established. However, the effectiveness of such treatment &ge;10 days after illness onset has not yet been clarified.
Intravenous immunoglobulin treatment &ge;10 days after illness onset was observed to be effective for achieving inflammation resolution. Patients who are strongly suspected to have Kawasaki disease and demonstrate ongoing inflammation should therefore be treated as soon as possible. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X20?rss=1">
<title>Incidence and Timing of Presentation of Necrotizing Enterocolitis in Preterm Infants</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X20?rss=1</link>
<description><![CDATA[
Necrotizing enterocolitis (NEC) can present within the first week of life in term infants. In preterm infants, NEC usually appears after commencement of feeds and can occur between 2 and 3 weeks of life.
Among infants &lt;33 weeks&rsquo; gestation, NEC appears to occur at mean age of 7 days in more mature infants, whereas onset of NEC is delayed to 32 days of age in smaller, lower gestational age infants. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X21?rss=1">
<title>Co-occurring Conditions and Change in Diagnosis in Autism Spectrum Disorders</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X21?rss=1</link>
<description><![CDATA[
Mixed prevalence rates of co-occurring psychiatric and neurodevelopmental conditions have been reported in children diagnosed with an autism spectrum disorder (ASD). ASD diagnoses remain fairly stable within a continuum, but some do not meet criteria for an ASD diagnosis years after initial diagnosis.
Co-occurring neurodevelopmental and psychiatric conditions may explain, in part, why the diagnosis of an ASD may change with age. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X22?rss=1">
<title>Maternal Asthma Medication Use and the Risk of Selected Birth Defects</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X22?rss=1</link>
<description><![CDATA[
Asthma is a common obstructive pulmonary disease experienced during pregnancy. Clinical guidelines recommend women with asthma maintain asthma medication use during pregnancy. Epidemiologic studies suggest an association between several types of defects and asthma or asthma medication use during pregnancy.
Data from a large, population-based, multicenter, case-control study was used. This provides the opportunity to study specific birth defects with minimal heterogeneity in case groups, as well as control for a variety of potential confounders. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X23?rss=1">
<title>Multicenter Analysis of Quality Indicators for Children Treated in the Emergency Department for Asthma</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X23?rss=1</link>
<description><![CDATA[
Studies of the association between process and outcome measures of the quality of acute asthma care for children have been mixed. These studies are limited by small, single-institution settings or by examining the association at the aggregate level.
This first multicenter analysis of the process-outcome association in acute asthma care for children revealed no association. Because the validity of process measures depends on association with outcomes, further study is needed before implementing existing process measures as performance metrics. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X24?rss=1">
<title>Nasal Continuous Positive Airway Pressure With Heliox in Preterm Infants With Respiratory Distress Syndrome</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X24?rss=1</link>
<description><![CDATA[
Nasal continuous positive airway pressure (NCPAP) is a noninvasive ventilatory support that may reduce the need for mechanical ventilation in preterm infants with respiratory distress syndrome. Heliox, a helium-oxygen mixture, has shown positive effects, especially in obstructive diseases.
NCPAP with heliox reduces the need for mechanical ventilation in preterm infants with respiratory distress syndrome in comparison with NCPAP with medical air. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X25?rss=1">
<title>A Decision-Tree Approach to Cost Comparison of Newborn Screening Strategies for Cystic Fibrosis</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X25?rss=1</link>
<description><![CDATA[
Although it has been shown that cystic fibrosis newborn screening is beneficial, the strategies vary widely, and there has been uncertainty about the costs and consequences of different algorithms and whether screening methods/decisions should be based on assumed cost differences.
This study contributes by offering a comparison of both costs, assessed comprehensively, and the consequences associated with the 2 most popular screening methodologies, immunoreactive trypsinogen/immunoreactive trypsinogen and immunoreactive trypsinogen/DNA, by using a decision-tree framework allowing variation in the model parameters. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X26?rss=1">
<title>Comparison of the US and Australian Cystic Fibrosis Registries: The Impact of Newborn Screening</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X26?rss=1</link>
<description><![CDATA[
Registries have been established in a number of countries to monitor the health of patients with cystic fibrosis. Few international comparisons have been made between registries. International data registry comparisons may be useful for informing best practice and benchmarking.
Registry comparisons are feasible but are limited by factors such as nonstandardization of data collection. Lung function was lower in Australian children with cystic fibrosis compared with their US counterparts after adjusting for the benefits of diagnosis after newborn screening. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X27?rss=1">
<title>Urinary Proteome Analysis to Exclude Severe Vesicoureteral Reflux</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X27?rss=1</link>
<description><![CDATA[
High-grade vesicoureteral reflux is a risk factor for impaired renal function. Diagnosis by voiding cystourethrography is invasive and highly uncomfortable. As only a minority of children show high-grade vesicoureteral reflux, this exposes the majority to unnecessary distress.
This case-control study proved that high-grade vesicoureteral reflux is identifiable with high sensitivity using urinary proteome analysis, based on capillary electrophoresis coupled to mass spectrometry in a cohort suspected of having vesicoureteral reflux, thus sparing the majority of children from invasive diagnostics. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X28?rss=1">
<title>Bronchoscopic Findings in Children With Chronic Wet Cough</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X28?rss=1</link>
<description><![CDATA[
Chronic wet cough is a common symptom well recognized by pediatricians. Protracted bacterial bronchitis is defined as more than 4 weeks of wet cough that responds to antibiotic treatment. Diagnosis of protracted bacterial bronchitis is not readily accepted by pediatricians
Children with chronic wet cough often have bronchitis, which is evident during bronchoscopy. Purulent bronchial secretions suggest the presence of bacterial infection. Children with chronic wet cough frequently have a bacterial infection of the lower airway. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X29?rss=1">
<title>Association of Center Volume With Mortality and Complications in Pediatric Heart Surgery</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X29?rss=1</link>
<description><![CDATA[
Previous analyses have suggested that center volume is associated with outcome in children undergoing heart surgery. There are limited data regarding factors that may mediate this volume&ndash;outcome relationship.
A multicenter analysis of 35 776 children revealed that the higher mortality observed at lower volume centers may be related to a higher rate of mortality in those with postoperative complications, rather than a higher rate of complications alone. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X30?rss=1">
<title>Social-Emotional Screening for Infants and Toddlers in Primary Care</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X30?rss=1</link>
<description><![CDATA[
Recommendations in pediatrics call for general developmental screening of young children; however, research suggests social-emotional development, in particular, is important as an initial indicator of general well-being versus risk, and may warrant inclusion in screening protocols.
Via a social-emotional screening program, significant percentages of children can be identified as being at risk for social-emotional problems, and colocation of an early childhood psychologist promotes the ability to effectively address young children&rsquo;s social-emotional development within their medical home. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X31?rss=1">
<title>Perioperative Methylprednisolone and Outcome in Neonates Undergoing Heart Surgery</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X31?rss=1</link>
<description><![CDATA[
Recent studies have called into question the benefit of perioperative corticosteroids in children undergoing heart surgery, but have been limited by small sample size, the lack of placebo control, and the grouping of various steroid regimens together in analysis.
We evaluated outcomes across methylprednisolone regimens versus no steroids in a large cohort of neonates and found no mortality or length-of-stay benefit associated with any regimen, and a higher risk of infection in certain subgroups. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X32?rss=1">
<title>Lead Poisoning in United States-Bound Refugee Children: Thailand-Burma Border, 2009</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X32?rss=1</link>
<description><![CDATA[
Refugee children arriving in the United States have had higher rates of elevated blood lead levels than US-born children. The Centers for Disease Control and Prevention recommends blood lead screening of all refugee children within 3 months after their arrival in the United States.
This is the first investigation we are aware of to examine and identify risk factors for lead poisoning among US-bound refugee children living in camps overseas, before their arrival in the United States. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X33?rss=1">
<title>Fetal and Maternal Candidate Single Nucleotide Polymorphism Associations With Cerebral Palsy: A Case-Control Study</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X33?rss=1</link>
<description><![CDATA[
Candidate genes involved in thrombophilia, inflammation, and preterm birth have previously been associated with cerebral palsy. Most studies to date have included small cohorts, did not allow for multiple testing, and require replication.
This study of children with cerebral palsy and their mothers did not confirm previously reported candidate gene associations. Prothrombin gene mutation was associated with hemiplegia in children born at term to mothers with a reported infection during pregnancy. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X34?rss=1">
<title>Pertussis Pseudo-outbreak Linked to Specimens Contaminated by Bordetella pertussis DNA From Clinic Surfaces</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X34?rss=1</link>
<description><![CDATA[
Pertussis is a poorly controlled vaccine-preventable disease. Verifying outbreaks is challenging owing to nonspecific clinical presentations and imperfect diagnostic tests. Exclusive reliance on highly sensitive polymerase chain reaction has been associated with pseudo-outbreaks.
Contamination of specimens with vaccine derived Bordetella pertussis DNA from pediatric clinic surfaces likely resulted in misdiagnoses. Standard practices, liquid transport medium, and lack of polymerase chain reaction cutoffs for discerning weakly positive (contaminant) DNA are contributory, but modifiable factors. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X35?rss=1">
<title>Genetic Causes of Macroglossia: Diagnostic Approach</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X35?rss=1</link>
<description><![CDATA[
Macroglossia is a clinical feature of several disorders and a common reason for additional diagnostic investigations during infancy. Limited research has been done on the evaluation of macroglossia when other features are not suggestive of Beckwith-Wiedemann syndrome.
All patients with apparently isolated macroglossia should have at least initial evaluation with abdominal ultrasounds and molecular studies for Beckwith-Wiedemann syndrome before a final diagnosis is given. Other common diagnoses included isolated macroglossia, chromosomal abnormalities, hypothyroidism, and mucopolysaccharidoses. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X36?rss=1">
<title>Calculation of Expected Body Weight in Adolescents With Eating Disorders</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X36?rss=1</link>
<description><![CDATA[
Eating disorders are characterized by preoccupation with weight and shape, which is manifested by a refusal to maintain a normal weight. An exact determination of expected body weight (EBW) is critical for diagnosis and clinical management of these disorders.
The McLaren and Moore methods present with several limitations when calculating EBW for adolescents with eating disorders. A commonly agreed upon method for EBW calculation such as the BMI percentile method is recommended for clinical and research purposes. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X37?rss=1">
<title>Intrapartum Temperature Elevation, Epidural Use, and Adverse Outcome in Term Infants</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X37?rss=1</link>
<description><![CDATA[
Previous observational studies and randomized trials have reported an association between the use of epidural analgesia for pain relief in labor and intrapartum maternal fever. Studies have also reported an increase in adverse neonatal outcomes with intrapartum maternal fever.
Among low-risk women receiving epidural analgesia, intrapartum maternal temperature &gt;99.5&deg;F was associated with adverse neonatal outcomes, with the rate of adverse outcomes increasing directly with maximum maternal temperature. Without temperature elevation, epidural use was not associated with adverse neonatal outcomes. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X38?rss=1">
<title>Genetic and Environmental Components of Neonatal Weight Gain in Preterm Infants</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/X38?rss=1</link>
<description><![CDATA[
Several studies have focused on birth weight heritability, reporting results that range between 40% and 80%. Few studies have focused on the process of weight gain and were mainly based on heterogeneous samples of infants.
The present work looks at a uniform set of healthy preterm newborn twins. The resulting high heritability estimate could suggest using the inclusion criteria to identify genes that regulate postnatal weight gain or failure. (Read the full article)
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/full/129/2/201?rss=1">
<title>I-PASS, a Mnemonic to Standardize Verbal Handoffs</title>
<link>http://pediatrics.aappublications.org/cgi/content/full/129/2/201?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/205?rss=1">
<title>Drinking Frequency as a Brief Screen for Adolescent Alcohol Problems</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/205?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Routine alcohol screening of adolescents in pediatric settings is recommended, and could be facilitated by a very brief empirically validated alcohol screen based on alcohol consumption. This study used national sample data to test the screening performance of 3 alcohol consumption items (ie, frequency of use in the past year, quantity per occasion, frequency of heavy episodic drinking) in identifying youth with alcohol-related problems.

METHODS:
Data were from youth aged 12 to 18 participating in the annual National Survey on Drug Use and Health from 2000 to 2007. The screening performance of 3 alcohol consumption items was tested, by age and gender, against 2 outcomes: any Diagnostic and Statistical Manual, Fourth Edition alcohol use disorder symptom ("moderate"-risk outcome), and a diagnosis of Diagnostic and Statistical Manual, Fourth Edition alcohol dependence ("high"-risk outcome).

RESULTS:
Prevalence of the 2 outcomes increased with age: any alcohol use disorder symptom ranged from 1.4% to 29.2%; alcohol dependence ranged from 0.2% to 5.3%. Frequency of drinking had higher sensitivity and specificity in identifying both outcomes, compared with quantity per occasion and heavy episodic drinking frequency. For both outcomes, results indicate the utility of similar cut points for drinking frequency for males and females at each age. Age-specific frequency cut points, however, are recommended for both moderate- and high-risk outcomes to maximize screening performance.

CONCLUSIONS:
Drinking frequency provides an empirically supported brief screen to efficiently identify youth with alcohol-related problems.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/213?rss=1">
<title>Hepatitis A Vaccination Coverage Among Adolescents in the United States</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/213?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Hepatitis A infection causes severe disease among adolescents and adults. The Advisory Committee on Immunization Practices instituted incremental recommendations for hepatitis A vaccination (HepA) at 2 years of age based on risk (1996), in selected states (1999), and universally at 1 year of age, with vaccination through 18 years of age based on risk or desire for protection (2006). We assessed adolescent HepA coverage in the United States and factors independently associated with vaccination.

METHODS:
Data from the 2009 National Immunization Survey&ndash;Teen (n = 20 066) were analyzed to determine &ge;1- and &ge;2-dose HepA coverage among adolescents 13 to 17 years of age. We used bivariate and multivariable analyses to test associations between HepA initiation and sociodemographic characteristics stratified by state groups: group 1, universal child vaccination since 1999; group 2, consideration for child vaccination since 1999; group 3, universal child vaccination at 1 year of age since 2006.

RESULTS:
In 2009, national 1-dose HepA coverage among adolescents was 42.0%. Seventy percent of vaccinees completed the 2-dose series. One-dose coverage was 74.3% among group 1 states, 54.0% for group 2 states, and 27.8% for group 3 states. The adjusted prevalence ratios of vaccination initiation were highest for states with a vaccination requirement and for adolescents whose providers recommended HepA.

CONCLUSIONS:
HepA coverage was low among most adolescents in the United States in 2009 leaving a large population susceptible to hepatitis A infection maturing into adulthood.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/222?rss=1">
<title>Cardiac Screening Prior to Stimulant Treatment of ADHD: A Survey of US-Based Pediatricians</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/222?rss=1</link>
<description><![CDATA[
OBJECTIVES:
To determine pediatricians&rsquo; attitudes, barriers, and practices regarding cardiac screening before initiating treatment with stimulants for attention-deficit/hyperactivity disorder.

METHODS:
A survey of 1600 randomly selected, practicing US pediatricians with American Academy of Pediatrics membership was conducted. Multivariate models were created for 3 screening practices: (1) performing an in-depth cardiac history and physical (H &amp; P) examination, (2) discussing potential stimulant-related cardiac risks, and (3) ordering an electrocardiogram (ECG).

RESULTS:
Of 817 respondents (51%), 525 (64%) met eligibility criteria. Regarding attitudes, pediatricians agreed that both the risk for sudden cardiac death (SCD) (24%) and legal liability (30%) were sufficiently high to warrant cardiac assessment; 75% agreed that physicians were responsible for informing families about SCD risk. When identifying cardiac disorders, few (18%) recognized performing an in-depth cardiac H &amp; P as a barrier; in contrast, 71% recognized interpreting a pediatric ECG as a barrier. When asked about cardiac screening practices before initiating stimulant treatment for a recent patient, 93% completed a routine H &amp; P, 48% completed an in-depth cardiac H &amp; P, and 15% ordered an ECG. Almost half (46%) reported discussing stimulant-related cardiac risks. Multivariate modeling indicated that &ge;1 of these screening practices were associated with physicians&rsquo; attitudes about SCD risk, legal liability, their responsibility to inform about risk, their ability to perform an in-depth cardiac H &amp; P, and family concerns about risk.

CONCLUSIONS:
Variable pediatrician attitudes and cardiac screening practices reflect the limited evidence base and conflicting guidelines regarding cardiac screening. Barriers to identifying cardiac disorders influence practice.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/231?rss=1">
<title>Public Attitudes Regarding the Use of Residual Newborn Screening Specimens for Research</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/231?rss=1</link>
<description><![CDATA[
BACKGROUND AND OBJECTIVES:
Many state newborn screening (NBS) programs retain residual NBS bloodspots after the completion of screening. Potential uses for residual specimens include laboratory quality assurance, biomedical research, and, rarely, forensic applications. Our objective was to evaluate public opinion about the policies and practices relevant to the retention and use of residual bloodspots for biomedical research.

METHODS:
A total of 3855 respondents were recruited using 3 methods: focus groups (n = 157), paper or telephone surveys (n = 1418), and a Knowledge Networks panel (n = 2280). Some participants (n = 1769) viewed a 22-minute movie about the retention and use of residual specimens while other participants were provided only written information about this practice. All participants were surveyed using a 38-item questionnaire.

RESULTS:
A diverse set of participants was recruited. Respondents were very supportive of NBS in general and accepting of the use of residual bloodspots for important research activities. Respondents were evenly divided on the acceptability of NBS without parental permission, but the majority of respondents supported the use of an "opt-in" process for parental permission for residual bloodspot retention and use. Viewing the educational movie was associated with greater support for bloodspot retention and use.

CONCLUSIONS:
Our results show that the general public surveyed here was supportive of NBS and residual sample retention and research use. However, there was a clear preference for an informed permission process for parents regarding these activities. Education about NBS was associated with a higher level of support and may be important to maintain public trust in these important programs.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/239?rss=1">
<title>Citizens&#x27; Values Regarding Research With Stored Samples From Newborn Screening in Canada</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/239?rss=1</link>
<description><![CDATA[
OBJECTIVES:
Newborn screening (NBS) programs may store bloodspot samples and use them for secondary purposes. Recent public controversies and lawsuits over storage and secondary uses underscore the need to engage the public on these issues. We explored Canadian values regarding storage and use of NBS samples for various purposes and the forms of parental choice for anonymous research with NBS samples.

METHODS:
We conducted a mixed-methods, public engagement study comprising 8 focus groups (n = 60), an educational component, deliberative discussion, and pre- and post-questionnaires assessing knowledge and values toward storage and parental choice.

RESULTS:
Canadian citizens supported the storage of NBS samples for quality control, confirmatory diagnosis, and future anonymous research (&gt;90%). There was broad support for use of NBS samples for anonymous research; however, opinions were split about the extent of parental decision-making. Support for a "routinized" approach rested on trust in authorities, lack of concern for harms, and an assertion that the population&rsquo;s interest took priority over the interests of individuals. Discomfort stemmed from distrust in authorities, concern for harms, and prioritizing individual interests, which supported more substantive parental choice. Consensus emerged regarding the need for greater transparency about the storage and secondary use of samples.

CONCLUSIONS:
Our study provides novel insights into the values that underpin citizens&rsquo; acceptance and discomfort with routine storage of NBS samples for research, and supports the need to develop well-designed methods of public education and civic discourse on the risks and benefits of the retention and secondary use of NBS samples.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/248?rss=1">
<title>The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and Adolescents</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/248?rss=1</link>
<description><![CDATA[
BACKGROUND:
The risk of immune thrombocytopenic purpura (ITP) after childhood vaccines other than measles-mumps-rubella vaccine (MMR) is unknown.

METHODS:
Using data from 5 managed care organizations for 2000 to 2009, we identified a cohort of 1.8 million children ages 6 weeks to 17 years. Potential ITP cases were identified by using diagnostic codes and platelet counts. All cases were verified by chart review. Incidence rate ratios were calculated comparing the risk of ITP in risk (1 to 42 days after vaccination) and control periods.

RESULTS:
There were 197 chart-confirmed ITP cases out of 1.8 million children in the cohort. There was no elevated risk of ITP after any vaccine in early childhood other than MMR in the 12- to 19-month age group. There was a significantly elevated risk of ITP after hepatitis A vaccine at 7 to 17 years of age, and for varicella vaccine and tetanus-diphtheria-acellular pertussis vaccine at 11 to 17 years of age. For hepatitis A, varicella, and tetanus-diphtheria-acellular pertussis vaccines, elevated risks were based on one to two vaccine-exposed cases. Most cases were acute and mild with no long-term sequelae.

CONCLUSIONS:
ITP is unlikely after early childhood vaccines other than MMR. Because of the small number of exposed cases and potential confounding, the possible association of ITP with hepatitis A, varicella, and tetanus-diphtheria-acellular pertussis vaccines in older children requires further investigation.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e254?rss=1">
<title>Predictors of Cognitive Function and Recovery 10 Years After Traumatic Brain Injury in Young Children</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e254?rss=1</link>
<description><![CDATA[
BACKGROUND AND OBJECTIVES:
Childhood traumatic brain injury (TBI) has implications for functional outcomes, but few studies have documented long-term outcomes. The purpose of this study was to plot recovery of cognitive and functional skills after early childhood TBI to 10 years postinjury and to identify the contribution of injury, environment, preinjury characteristics, and acute functional recovery.

METHODS:
 Subjects were recruited consecutively to this prospective, longitudinal study, which used a between-factor design, with injury severity as the independent variable. Forty children with TBI aged 2 and 7 years were recruited on admission to a tertiary pediatric hospital, divided according to injury severity, and compared with 16 healthy controls acutely and 12 and 30 months and 10 years postinjury. Cognition, adaptive ability, executive function, and social/behavioral skills were examined.

RESULTS:
Children with severe TBI had poorest outcomes, with deficits greatest for cognition. Recovery trajectories were similar across severity groups but with significant gains in verbal skills from 12 and 30 months to 12 months and 10 years. Predictors of outcome included preinjury ability (for adaptive function) and family function (social/behavioral skills).

CONCLUSIONS:
Results confirm a high risk of persisting deficits after severe TBI in early childhood. Children with less severe TBI appear to recover to function normally. Contrary to speculation about "growing into deficits," after protracted recovery to 30 months, young children make age-appropriate progress at least to 10 years postinsult. Environmental factors were found to contribute to adaptive and social/behavioral recovery.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/256?rss=1">
<title>A National Profile of Childhood Epilepsy and Seizure Disorder</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/256?rss=1</link>
<description><![CDATA[
OBJECTIVE:
To determine sociodemographics, patterns of comorbidity, and function of US children with reported epilepsy/seizure disorder.

METHODS:
Bivariate and multivariable cross-sectional analysis of data from the National Survey of Children&rsquo;s Health (2007) on 91 605 children ages birth to 17 years, including 977 children reported by their parents to have been diagnosed with epilepsy/seizure disorder.

RESULTS:
Estimated lifetime prevalence of epilepsy/seizure disorder was 10.2/1000 (95% confidence interval [CI]: 8.7&ndash;11.8) or 1%, and of current reported epilepsy/seizure disorder was 6.3/1000 (95% CI: 4.9&ndash;7.8). Epilepsy/seizure disorder prevalence was higher in lower-income families and in older, male children. Children with current reported epilepsy/seizure disorder were significantly more likely than those never diagnosed to experience depression (8% vs 2%), anxiety (17% vs 3%), attention-deficit/hyperactivity disorder (23% vs 6%), conduct problems (16% vs 3%), developmental delay (51% vs 3%), autism/autism spectrum disorder (16% vs 1%), and headaches (14% vs 5%) (all P &lt; .05). They had greater risk of limitation in ability to do things (relative risk: 9.22; 95% CI: 7.56&ndash;11.24), repeating a school grade (relative risk: 2.59; CI: 1.52&ndash;4.40), poorer social competence and greater parent aggravation, and were at increased risk of having unmet medical and mental health needs. Children with prior but not current seizures largely had intermediate risk.

CONCLUSIONS:
In a nationally representative sample, children with seizures were at increased risk for mental health, developmental, and physical comorbidities, increasing needs for care coordination and specialized services. Children with reported prior but not current seizures need further study to establish reasons for their higher than expected levels of reported functional limitations.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e262?rss=1">
<title>Intellectual, Behavioral, and Social Outcomes of Accidental Traumatic Brain Injury in Early Childhood</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e262?rss=1</link>
<description><![CDATA[
OBJECTIVE:
The intellectual, behavioral, and social function of children who sustained traumatic brain injury (TBI) before 3 years of age were compared with a group of uninjured children. The role of injury and environmental factors in recovery was examined.

METHODS:
A group of 53 children who sustained a TBI before 3 years of age (20 mild and 33 moderate/severe) and 27 uninjured children (control group) were assessed on an IQ measure and parent measures of behavior and social skills. Children were aged 4 to 6 years and were an average of 40 months since sustaining their injury.

RESULTS:
There were no demographic differences between the groups. Although all group scores were in the average range, children with moderate/severe TBI performed significantly below uninjured children on an IQ measure. No significant differences were found on parent behavior ratings, although effect sizes between groups were medium to large. No differences were found for social skills. All outcomes were significantly influenced by environmental but not injury factors.

CONCLUSIONS:
Moderate/severe TBI at an early age appears to be associated with lowered intellectual function and possibly behavior problems. A child&rsquo;s environment influences cognitive and behavior function after TBI.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/265?rss=1">
<title>Societal Values and Policies May Curtail Preschool Children&#x27;s Physical Activity in Child Care Centers</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/265?rss=1</link>
<description><![CDATA[
BACKGROUND AND OBJECTIVES:
Three-fourths of US preschool-age children are in child care centers. Children are primarily sedentary in these settings, and are not meeting recommended levels of physical activity. Our objective was to identify potential barriers to children&rsquo;s physical activity in child care centers.

METHODS:
Nine focus groups with 49 child care providers (55% African American) were assembled from 34 centers (inner-city, suburban, Head Start, and Montessori) in Cincinnati, Ohio. Three coders independently analyzed verbatim transcripts for themes. Data analysis and interpretation of findings were verified through triangulation of methods.

RESULTS:
We identified 3 main barriers to children&rsquo;s physical activity in child care: (1) injury concerns, (2) financial, and (3) a focus on "academics." Stricter licensing codes intended to reduce children's injuries on playgrounds rendered playgrounds less physically challenging and interesting. In addition, some parents concerned about potential injury, requested staff to restrict playground participation for their children. Small operating margins of most child care centers limited their ability to install abundant playground equipment. Child care providers felt pressure from state mandates and parents to focus on academics at the expense of gross motor play. Because children spend long hours in care and many lack a safe place to play near their home, these barriers may limit children's only opportunity to engage in physical activity.

CONCLUSIONS:
Societal priorities for young children&mdash;safety and school readiness&mdash;may be hindering children&rsquo;s physical development. In designing environments that optimally promote children&rsquo;s health and development, child advocates should think holistically about potential unintended consequences of policies.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e269?rss=1">
<title>Randomized Trial of Oral Versus Sequential IV/Oral Antibiotic for Acute Pyelonephritis in Children</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e269?rss=1</link>
<description><![CDATA[
OBJECTIVE:
To confirm whether oral antibiotic treatment is as efficacious as sequential intravenous/oral antibiotic treatment in the prevention of renal scarring in children with acute pyelonephritis and scintigraphy-documented acute lesions.

METHODS:
In a prospective multicenter trial, children aged 1 to 36 months with their first case of acute pyelonephritis, a serum procalcitonin concentration &ge;0.5 ng/mL, no known uropathy, and a normal ultrasound exam were randomized into 2 treatment groups. They received either oral cefixime for 10 days or intravenous ceftriaxone for 4 days followed by oral cefixime for 6 days. Patients with acute renal lesions detected on early dimercaptosuccinic acid scintigraphy underwent a follow-up scintigraphy 6 to 8 months later.

RESULTS:
The study included 171 infants and children. There were no significant differences between the 2 groups in any clinical characteristic. Initial scintigraphy results were abnormal for 119 children. Ninety-six children were measured for renal scarring at the follow-up scintigraphy (per protocol analysis population). The incidence of renal scarring was 30.8% in the oral treatment group and 27.3% for children who received the sequential treatment.

CONCLUSIONS:
Although this trial does not statistically demonstrate the noninferiority of oral treatment compared with the sequential treatment, our study confirmed the results of previously published reports and therefore supports the use of an oral antibiotic treatment of primary episodes of acute pyelonephritis in infants and young children.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/275?rss=1">
<title>Trends in US Pediatric Drowning Hospitalizations, 1993-2008</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/275?rss=1</link>
<description><![CDATA[
BACKGROUND:
In the United States, drowning is the second leading cause of unintentional injury death in children aged 1 to 19 years, accounting for nearly 1100 deaths per year. Although a decline in overall fatal drowning deaths among children has been noted, national trends and disparities in pediatric drowning hospitalizations have not been reported.

METHODS:
To describe trends in pediatric drowning in the United States and provide national benchmarks for state and regional comparisons, we analyzed existing data (1993&ndash;2008) from the Nationwide Inpatient Sample, the largest, longitudinal, all-payer inpatient care database in the United States. Children aged 0 to 19 years were included. Annual rates of drowning-related hospitalizations were determined, stratified by age, gender, and outcome.

RESULTS:
From 1993 to 2008, the estimated annual incidence rate of pediatric hospitalizations associated with drowning declined 49% from 4.7 to 2.4 per 100 000 (P &lt; .001). The rates declined for all age groups and for both males and females. The hospitalization rate for males remained consistently greater than for females at each point in time. Rates of fatal drowning hospitalization declined from 0.5 (95% confidence interval, 0.4&ndash;0.7) deaths per 100 000 in 1993&ndash;1994 to 0.3 (95% confidence interval, 0.2&ndash;0.4) in 2007&ndash;2008 (P &lt; .01). No difference was observed in the mean hospital length of stay over time.

CONCLUSIONS:
Pediatric hospitalization rates for drowning have decreased over the past 16 years. Our study provides national estimates of pediatric drowning hospitalization that can be used as benchmarks to target and assess prevention strategies.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e276?rss=1">
<title>Prevalence, Patterns, and Persistence of Sleep Problems in the First 3 Years of Life</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e276?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Examine the prevalence, patterns, and persistence of parent-reported sleep problems during the first 3 years of life.

METHODS:
Three hundred fifty-nine mother/child pairs participated in a prospective birth cohort study. Sleep questionnaires were administered to mothers when children were 6, 12, 24, and 36 months old. Sleep variables included parent response to a nonspecific query about the presence/absence of a sleep problem and 8 specific sleep outcome domains: sleep onset latency, sleep maintenance, 24-hour sleep duration, daytime sleep/naps, sleep location, restlessness/vocalization, nightmares/night terrors, and snoring.

RESULTS:
Prevalence of a parent-reported sleep problem was 10% at all assessment intervals. Night wakings and shorter sleep duration were associated with a parent-reported sleep problem during infancy and early toddlerhood (6&ndash;24 months), whereas nightmares and restless sleep emerged as associations with report of a sleep problem in later developmental periods (24&ndash;36 months). Prolonged sleep latency was associated with parent report of a sleep problem throughout the study period. In contrast, napping, sleep location, and snoring were not associated with parent-reported sleep problems. Twenty-one percent of children with sleep problems in infancy (compared with 6% of those without) had sleep problems in the third year of life.

CONCLUSIONS:
Ten percent of children are reported to have a sleep problem at any given point during early childhood, and these problems persist in a significant minority of children throughout early development. Parent response to a single-item nonspecific sleep query may overlook relevant sleep behaviors and symptoms associated with clinical morbidity.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/282?rss=1">
<title>Value of Follow-up Examinations of Children and Adolescents Evaluated for Sexual Abuse and Assault</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/282?rss=1</link>
<description><![CDATA[
OBJECTIVE:
The purpose of this study was to determine whether follow-up examinations of suspected victims of child sexual abuse influence medical diagnosis or treatment.

METHODS:
A retrospective chart review of patients with initial and follow-up examinations (examinations 1 and 2, respectively) over a 5-year study period was conducted. Patient and abuse characteristics, interval between examinations and abuse, and examiner experience levels were collected; examination findings and test results for sexually transmitted infections (STIs) were compared for examinations 1 and 2.

RESULTS:
Among 727 patients, examination 2 resulted in a change in interpretation of trauma likelihood in 129 (17.7%) patients and identified STIs in 47 (6.5%) patients. Changes in trauma likelihood and detection of additional STIs during follow-up examinations were more likely in adolescent, female, and sexually active patients and those with a history of genital&ndash;genital contact, unknown examination 1 findings, or drug-facilitated sexual assault. Although examination 2 was less likely to affect the interpretation of trauma likelihood and STIs in preadolescent patients, a change in interpretation of trauma likelihood was noted for 49 (15.5%) of these patients, and 16 (5.1%) were diagnosed with a new STI on examination 2. The level of clinician experience during examination 1 did affect the likelihood of changes in examination findings during examination 2.

CONCLUSIONS:
Follow-up examinations by specialists affected the interpretation of trauma and detection of STIs in ~23% of pediatric patients undergoing sexual abuse assessments.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e285?rss=1">
<title>RCT of Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e285?rss=1</link>
<description><![CDATA[
BACKGROUND:
Infections with viruses causing upper respiratory tract infection (URI) are associated with increased leukotriene levels in the upper airways. Montelukast, a selective leukotriene-receptor antagonist, is an effective treatment of asthma and allergic rhinitis.

OBJECTIVE:
To determine whether prophylactic treatment with montelukast reduces the incidence and severity of URI in children.

METHODS:
A randomized, double-blind, placebo-controlled study was performed in 3 primary care pediatric ambulatory clinics in Israel. Healthy children aged 1 to 5 years were randomly assigned in a 1:1 ratio to receive 12-week treatment with 4 mg oral montelukast or look-alike placebo. Patients were excluded if they had a previous history of reactive airway disease. A study coordinator contacted the parents by phone once a week to obtain information regarding the occurrence of acute respiratory episodes. The parents received a diary card to record any acute symptoms of URI. The primary outcome measure was the number of URI episodes.

RESULTS:
Three hundred children were recruited and randomly assigned into montelukast (n = 153) or placebo (n = 147) groups. One hundred thirty-one (85.6%) of the children treated with montelukast and 129 (87.7%) of the children treated with placebo completed 12 weeks of treatment. The number of weeks in which URI was reported was 30.4% in children treated with montelukast and 30.7% in children treated with placebo. There was no significant difference in any of the secondary variables between the groups.

CONCLUSIONS:
In preschool-aged children, 12-week treatment with montelukast, compared with placebo, did not reduce the incidence of URI.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/290?rss=1">
<title>Carpooling and Booster Seats: A National Survey of Parents</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/290?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Booster seat use among school-aged children has been consistently lower than national goals. In this study, we sought to explore associations between parental experiences with booster seats and carpooling.

METHODS:
We conducted a cross-sectional Web-based survey of a nationally representative panel of US parents in January 2010. As part of a larger survey, parents of 4- to 8-year-old children responded to 12 questions related to booster seats and carpooling.

RESULTS:
Of 1612 parents responding to the full survey (response rate = 71%), 706 had a 4- to 8-year-old child and 681 met inclusion rules. Most parents (76%) reported their child used a safety seat when riding in the family car. Of children reported to use seat belts, 74% did so in accordance with their state law. Parent report of child safety seat use was associated with younger child age and with the presence of state booster seat laws. Sixty-four percent of parents carpool. Among parents who carpool and whose children use a child safety seat: 79% indicated they would always ask another driver to use a booster seat for their child and 55% reported they always have their child use their booster seat when driving friends who do not have boosters.

CONCLUSIONS:
Carpooling is a common driving situation during which booster seat use is inconsistent. Social norms and self-efficacy are associated with booster seat use. Clinicians who care for children should increase efforts to convey the importance of using the size-appropriate restraint for every child on every trip.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e291?rss=1">
<title>Late Intravenous Immunoglobulin Treatment in Patients With Kawasaki Disease</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e291?rss=1</link>
<description><![CDATA[
OBJECTIVE:
To evaluate the effectiveness of intravenous immunoglobulin (IVIG) treatment of Kawasaki disease &ge;10 days after illness onset.

METHODS:
We selected patients initially treated with IVIG on days 11 to 20 in the database of the 20th nationwide survey in Japan. We then selected pair-matched control subjects of the same gender and age, who were initially treated with IVIG on days 4 to 8 with the same dose at the same institutions. We compared the proportions of additional treatments and coronary artery lesions (CALs) between the groups. We also compared fractional changes in various laboratory data before and after IVIG. Fractional change was defined as follows: (Y &ndash; X)/X, in which X represents the data before treatment and Y the data after treatment.

RESULTS:
One hundred fifty patients (75 pairs) were studied. The proportion of patients who received additional treatments among those given initial IVIG after days 10 was slightly lower than those treated earlier (12% vs 16%). The fractional changes in the white blood cell count, % neutrophils, and C-reactive protein were similar. Among all patients, the proportions of CALs during the convalescent phase were significantly higher in the late than in the early group (27% vs 1%). Among patients who had not developed CALs before initial treatment, the proportions with CALs during the acute phase were similar (8% vs 8%).

CONCLUSIONS:
IVIG treatment &ge;10 days after illness onset achieves resolution of inflammation but was found to be insufficient for preventing CALs.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e298?rss=1">
<title>Incidence and Timing of Presentation of Necrotizing Enterocolitis in Preterm Infants</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e298?rss=1</link>
<description><![CDATA[
OBJECTIVES:
To examine the variation in the incidence and to identify the timing of the presentation of necrotizing enterocolitis (NEC) in a cohort of preterm infants within the Canadian Neonatal Network (CNN).

METHODS:
This was a population-based cohort of 16 669 infants with gestational age (GA) &lt;33 weeks, admitted to 25 NICUs participating in the CNN between January 1, 2003, and December 31, 2008. Variations in NEC incidence among the participating NICUs for the study period were examined. We categorized early-onset NEC as occurring at &lt;14 days of age and late-onset NEC occurring at &ge;14 days. Multivariate logistic regression analysis was performed to identify risk factors for early-onset NEC.

RESULTS:
The overall incidence of NEC was 5.1%, with significant variation in the risk adjusted incidence among the participating NICUs in the CNN. Early-onset NEC occurred at a mean of 7 days compared with 32 days for late-onset NEC. Early-onset NEC infants had lower incidence of respiratory distress syndrome, patent ductus treated with indomethacin, less use of postnatal steroids, and shorter duration of ventilation days. Multivariate logistic regression analysis identified that greater GA and vaginal delivery were associated with increased risk of early-onset NEC.

CONCLUSIONS:
Among infants &lt;33 weeks&rsquo; gestation, NEC appears to present at mean age of 7 days in more mature infants, whereas onset of NEC is delayed to 32 days of age in smaller, lower GA infants. Further studies are required to understand the etiology of this disease process.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/299?rss=1">
<title>Oral Sucrose and &#x22;Facilitated Tucking&#x22; for Repeated Pain Relief in Preterms: A Randomized Controlled Trial</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/299?rss=1</link>
<description><![CDATA[
OBJECTIVES:
To test the comparative effectiveness of 2 nonpharmacologic pain-relieving interventions administered alone or in combination across time for repeated heel sticks in preterm infants.

METHODS:
A multicenter randomized controlled trial in 3 NICUs in Switzerland compared the effectiveness of oral sucrose, facilitated tucking (FT), and a combination of both interventions in preterm infants between 24 and 32 weeks of gestation. Data were collected during the first 14 days of their NICU stay. Three phases (baseline, heel stick, recovery) of 5 heel stick procedures were videotaped for each infant. Four independent experienced nurses blinded to the heel stick phase rated 1055 video sequences presented in random order by using the Bernese Pain Scale for Neonates, a validated pain tool.

RESULTS:
Seventy-one infants were included in the study. Interrater reliability was high for the total Bernese Pain Scale for Neonates score (Cronbach&rsquo;s &alpha;: 0.90&ndash;0.95). FT alone was significantly less effective in relieving repeated procedural pain (P &lt; .002) than sucrose (0.2 mL/kg). FT in combination with sucrose seemed to have added value in the recovery phase with lower pain scores (P = .003) compared with both the single-treatment groups. There were no significant differences in pain responses across gestational ages.

CONCLUSIONS:
Sucrose with and without FT had pain-relieving effects even in preterm infants of &lt;32 weeks of gestation having repeated pain exposures. These interventions remained effective during repeated heel sticks across time. FT was not as effective and cannot be recommended as a nonpharmacologic pain relief intervention for repeated pain exposure.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e305?rss=1">
<title>Co-occurring Conditions and Change in Diagnosis in Autism Spectrum Disorders</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e305?rss=1</link>
<description><![CDATA[
OBJECTIVE:
This study aimed to investigate descriptive characteristics and co-occurring neurodevelopmental and psychiatric conditions in young children, children, and adolescents with a current and consistent or past but not current (PBNC) diagnosis of autism spectrum disorder (ASD) and how such characteristics and conditions may engender a change in diagnosis of an ASD.

METHODS:
Cross-sectional data of 1366 children with a parent-reported current or PBNC ASD diagnosis were obtained from the National Survey of Children&rsquo;s Health 2007 data set across 3 developmental stages: young children (aged 3&ndash;5 years), children (aged 6&ndash;11 years), and adolescents (aged 12&ndash;17 years). Multinomial logistic regression was used to examine demographic characteristics and co-occurring conditions that differentiate the groups with a current ASD from groups with a PBNC ASD.

RESULTS:
Results indicated the co-occurring conditions that distinguish groups currently diagnosed with an ASD from groups with a PBNC ASD diagnosis. In young children, current moderate/severe learning disability, and current moderate/severe developmental delay; in children, past speech problem, current moderate/severe anxiety, and past hearing problem; and in adolescents, current moderate/severe speech problem, current mild seizure/epilepsy, and past hearing problem.

CONCLUSIONS:
These findings suggest that the presence of co-occurring psychiatric and neurodevelopmental conditions are associated with a change in ASD diagnosis. Questions remain as to whether changes in diagnosis of an ASD are due to true etiologic differences or shifts in diagnostic determination.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/309?rss=1">
<title>Prospective Study of Sunburn and Sun Behavior Patterns During Adolescence</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/309?rss=1</link>
<description><![CDATA[
OBJECTIVES:
Early childhood UV light radiation (UVR) exposures have been shown to be associated with melanoma development later in life. The objective of this study was to assess sunburn and changes in sunburn and sun behaviors during periadolescence.

METHODS:
A prospective, population-based study was conducted in fifth-grade children (~10 years of age) from Framingham, Massachusetts. Surveys were administered at baseline (September&ndash;October 2004) and again 3 years later (September&ndash;October 2007). Surveys were analyzed to assess prevalence of reported sunburn and sun behaviors and to examine changes in response over the follow-up period.

RESULTS:
Data were analyzed from 360 participants who had complete information regarding sunburn at both time points. In 2004, ~53% of the students reported having at least 1 sunburn during the previous summer, and this proportion did not significantly change by 2007 (55%, P = .79), whereas liking a tan and spending time outside to get a tan significantly increased (P &lt; .001). In 2004, 50% of students reported "often or always" use of sunscreen when outside for at least 6 hours in the summer; this proportion dropped to 25% at the follow-up evaluation (P &lt; .001).

CONCLUSIONS:
With at least 50% of children experiencing sunburns before age 11 and again 3 years later, targeting children in pediatric offices and community settings regarding unprotected UV exposure may be a practical approach. Because periadolescence is a time of volatility with regard to sun behaviors, learning more about children who receive sunburns versus those who avoid them is a critical research task.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e317?rss=1">
<title>Maternal Asthma Medication Use and the Risk of Selected Birth Defects</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e317?rss=1</link>
<description><![CDATA[
OBJECTIVES:
Approximately 4% to 12% of pregnant women have asthma; few studies have examined the effects of maternal asthma medication use on birth defects. We examined whether maternal asthma medication use during early pregnancy increased the risk of selected birth defects.

METHODS:
National Birth Defects Prevention Study data for 2853 infants with 1 or more selected birth defects (diaphragmatic hernia, esophageal atresia, small intestinal atresia, anorectal atresia, neural tube defects, omphalocele, or limb deficiencies) and 6726 unaffected control infants delivered from October 1997 through December 2005 were analyzed. Mothers of cases and controls provided telephone interviews of medication use and additional potential risk factors. Exposure was defined as maternal periconceptional (1 month prior through the third month of pregnancy) asthma medication use (bronchodilator or anti-inflammatory). Associations between maternal periconceptional asthma medication use and individual major birth defects were estimated by using adjusted odds ratios (aOR) and 95% confidence intervals (95%CI).

RESULTS:
No statistically significant associations were observed for maternal periconceptional asthma medication use and most defects studied; however, positive associations were observed between maternal asthma medication use and isolated esophageal atresia (bronchodilator use: aOR = 2.39, 95%CI = 1.23, 4.66), isolated anorectal atresia (anti-inflammatory use: aOR = 2.12, 95%CI = 1.09, 4.12), and omphalocele (bronchodilator and anti-inflammatory use: aOR = 4.13, 95%CI = 1.43, 11.95).

CONCLUSIONS:
Positive associations were observed for anorectal atresia, esophageal atresia, and omphalocele and maternal periconceptional asthma medication use, but not for other defects studied. It is possible that observed associations may be chance findings or may be a result of maternal asthma severity and related hypoxia rather than medication use.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/318?rss=1">
<title>Ethanol Locks to Prevent Catheter-Related Bloodstream Infections in Parenteral Nutrition: A Meta-Analysis</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/318?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Patients with pediatric intestinal failure (IF) depend on parenteral nutrition for growth and survival, but are at risk for complications, such as catheter-related bloodstream infections (CRBSIs). CRBSI prevention is crucial, as sepsis is an important cause of IF-associated liver disease and mortality. We aim to estimate the pooled effectiveness and safety of ethanol locks (ELs) in comparison with heparin locks (HLs) with regard to CRBSI rate and catheter replacements for pediatric IF patients with chronic parenteral nutrition dependence.

METHODS:
A systematic review without language restriction was performed on Medline (1948&ndash;2010), Embase (1980&ndash;2010), and conference programs and trial registries up to December 2010. Search terms included "Catheter-Related Infections," "Catheter," "Catheters, Indwelling," "alcohol," "ethanol," and "lock." Two authors identified 4 retrospective studies for the pediatric IF population. Double, independent data extraction using predefined data fields and risk of bias assessment (Newcastle-Ottawa scale) was performed.

RESULTS:
In comparison with HLs, ELs reduced the CRBSI-rate per 1000 catheter days by 7.67 events and catheter replacements by 5.07. EL therapy decreased the CRBSI rate by 81% and replacements by 72%. One hundred eight to 150 catheter days of EL exposure were necessary to prevent 1 CRBSI and 122 to 689 days of exposure avoided 1 catheter replacement. Adverse events were rare and included thrombotic events.

CONCLUSIONS:
In pediatric patients with IF, EL is a more effective alternative to HL. Adverse events include thrombotic events.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e325?rss=1">
<title>Multicenter Analysis of Quality Indicators for Children Treated in the Emergency Department for Asthma</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e325?rss=1</link>
<description><![CDATA[
OBJECTIVE:
To test the hypothesis that an association exists between process and outcome measures of the quality of acute asthma care provided to children in the emergency department.

METHODS:
Investigators at 14 US sites prospectively enrolled consecutive children 2 to 17 years of age presenting to the emergency department with acute asthma. In models adjusted for variables commonly associated with the quality of acute asthma care, we measured the association between 7 measures of concordance with national asthma guideline-recommended processes and 2 outcomes. Specifically, we modeled the association between 5 receipt/nonreceipt process measures and successful discharge and the association between 2 timeliness measures and admission.

RESULTS:
In this cohort of 1426 patients, 62% were discharged without relapse or ongoing symptoms (successful discharge), 15% were discharged with relapse or ongoing symptoms, and 24% were admitted. The composite score for receipt of all 5 receipt/nonreceipt process measures was 84%, and for timeliness measures, 57% receive a timely corticosteroid and 92% a timely &beta;-agonist. Our adjusted models showed no association between process and outcome measures, with 1 exception: timely &beta;-agonist administration was associated with admission, likely reflecting confounding by severity rather than a true process-outcome association.

CONCLUSIONS:
We found no clinically significant association between process and outcome quality measures in the delivery of asthma-related care to children in a multicenter study. Although the quality of emergency department care does not predict successful discharge, other factors, such as outpatient care, may better predict outcomes.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/330?rss=1">
<title>The Diet Factor in Attention-Deficit/Hyperactivity Disorder</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/330?rss=1</link>
<description><![CDATA[
This article is intended to provide a comprehensive overview of the role of dietary methods for treatment of children with attention-deficit/hyperactivity disorder (ADHD) when pharmacotherapy has proven unsatisfactory or unacceptable. Results of recent research and controlled studies, based on a PubMed search, are emphasized and compared with earlier reports. The recent increase of interest in this form of therapy for ADHD, and especially in the use of omega supplements, significance of iron deficiency, and the avoidance of the "Western pattern" diet, make the discussion timely.
Diets to reduce symptoms associated with ADHD include sugar-restricted, additive/preservative-free, oligoantigenic/elimination, and fatty acid supplements. Omega&ndash;3 supplement is the latest dietary treatment with positive reports of efficacy, and interest in the additive-free diet of the 1970s is occasionally revived. A provocative report draws attention to the ADHD-associated "Western-style" diet, high in fat and refined sugars, and the ADHD-free "healthy" diet, containing fiber, folate, and omega-3 fatty acids.
The literature on diets and ADHD, listed by PubMed, is reviewed with emphasis on recent controlled studies. Recommendations for the use of diets are based on current opinion of published reports and our practice experience. Indications for dietary therapy include medication failure, parental or patient preference, iron deficiency, and, when appropriate, change from an ADHD-linked Western diet to an ADHD-free healthy diet. Foods associated with ADHD to be avoided and those not linked with ADHD and preferred are listed.
In practice, additive-free and oligoantigenic/elimination diets are time-consuming and disruptive to the household; they are indicated only in selected patients. Iron and zinc are supplemented in patients with known deficiencies; they may also enhance the effectiveness of stimulant therapy. In patients failing to respond or with parents opposed to medication, omega-3 supplements may warrant a trial. A greater attention to the education of parents and children in a healthy dietary pattern, omitting items shown to predispose to ADHD, is perhaps the most promising and practical complementary or alternative treatment of ADHD.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e333?rss=1">
<title>Nasal Continuous Positive Airway Pressure With Heliox in Preterm Infants With Respiratory Distress Syndrome</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e333?rss=1</link>
<description><![CDATA[
OBJECTIVE:
To assess the therapeutic effects of breathing a low-density helium and oxygen mixture (heliox, 80% helium and 20% oxygen) in premature infants with respiratory distress syndrome (RDS) treated with nasal continuous positive airway pressure (NCPAP).

METHODS:
Infants born between 28 and 32 weeks of gestational age with radiologic findings and clinical symptoms of RDS and requiring respiratory support with NCPAP within the first hour of life were included. These infants were randomly assigned to receive either standard medical air (control group) or a 4:1 helium and oxygen mixture (heliox group) during the first 12 hours of enrollment, followed by medical air until NCPAP was no longer needed.

RESULTS:
From February 2008 to September 2010, 51 newborn infants were randomly assigned to two groups, 24 in the control group and 27 in the heliox group. NCPAP with heliox significantly decreased the risk of mechanical ventilation in comparison with NCPAP with medical air (14.8% vs 45.8%).

CONCLUSIONS:
Heliox increases the effectiveness of NCPAP in the treatment of RDS in premature infants.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/338?rss=1">
<title>Annual Summary of Vital Statistics: 2009</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/338?rss=1</link>
<description><![CDATA[
The number of births in the United States decreased by 3% between 2008 and 2009 to 4 130 665 births. The general fertility rate also declined 3% to 66.7 per 1000 women. The teenage birth rate fell 6% to 39.1 per 1000. Birth rates also declined for women 20 to 39 years and for all 5-year groups, but the rate for women 40 to 44 years continued to rise. The percentage of all births to unmarried women increased to 41.0% in 2009, up from 40.6% in 2008. In 2009, 32.9% of all births occurred by cesarean delivery, continuing its rise. The 2009 preterm birth rate declined for the third year in a row to 12.18%. The low-birth-weight rate was unchanged in 2009 at 8.16%. Both twin and triplet and higher order birth rates increased. The infant mortality rate was 6.42 infant deaths per 1000 live births in 2009. The rate is significantly lower than the rate of 6.61 in 2008. Linked birth and infant death data from 2007 showed that non-Hispanic black infants continued to have much higher mortality rates than non-Hispanic white and Hispanic infants. Life expectancy at birth was 78.2 years in 2009. Crude death rates for children and adolescents aged 1 to 19 years decreased by 6.5% between 2008 and 2009. Unintentional injuries and homicide, the first and second leading causes of death jointly accounted for 48.6% of all deaths to children and adolescents in 2009.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e339?rss=1">
<title>A Decision-Tree Approach to Cost Comparison of Newborn Screening Strategies for Cystic Fibrosis</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e339?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Because cystic fibrosis can be difficult to diagnose and treat early, newborn screening programs have rapidly developed nationwide but methods vary widely. We therefore investigated the costs and consequences or specific outcomes of the 2 most commonly used methods.

METHODS:
With available data on screening and follow-up, we used a simulation approach with decision trees to compare immunoreactive trypsinogen (IRT) screening followed by a second IRT test against an IRT/DNA analysis. By using a Monte Carlo simulation program, variation in the model parameters for counts at various nodes of the decision trees, as well as for costs, are included and applied to fictional cohorts of 100 000 newborns. The outcome measures included the numbers of newborns given a diagnosis of cystic fibrosis and costs of screening strategy at each branch and cost per newborn.

RESULTS:
Simulations revealed a substantial number of potential missed diagnoses for the IRT/IRT system versus IRT/DNA. Although the IRT/IRT strategy with commonly used cutoff values offers an average overall cost savings of $2.30 per newborn, a breakdown of costs by societal segments demonstrated higher out-of-pocket costs for families. Two potential system failures causing delayed diagnoses were identified relating to the screening protocols and the follow-up system.

CONCLUSIONS:
The IRT/IRT screening algorithm reduces the costs to laboratories and insurance companies but has more system failures. IRT/DNA offers other advantages, including fewer delayed diagnoses and lower out-of-pocket costs to families.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e348?rss=1">
<title>Comparison of the US and Australian Cystic Fibrosis Registries: The Impact of Newborn Screening</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e348?rss=1</link>
<description><![CDATA[
BACKGROUND AND OBJECTIVES:
National data registries for cystic fibrosis (CF) enable comparison of health statistics between countries. We examined the US and Australian CF data registries to compare demographics, clinical practice and outcome measures.

METHODS:
We compared the 2003 US and Australian registries. Differences in pulmonary and growth outcomes were assessed by creating models controlling for differences in age, gender, genotype, and diagnosis after newborn screening.

RESULTS:
Data on 12 994 US and 1220 Australian patients aged &le;18 years were analyzed. A significant difference was noted in the proportion who had been diagnosed after newborn screening (Australian 65.8% vs United States 7.2%; P &lt; .001). Australian children had significantly greater mean height percentile (41.0 vs 32.6; P &lt; .001) and weight percentile (43.5 vs 36.1; P = .028) than US children. Mean forced expiratory volume in 1 second (FEV1) percent predicted adjusted for age, gender, and genotype was similar in the 2 countries (P = .80). Patients diagnosed after newborn screening had higher mean FEV1 (5.3 [95% confidence interval (CI): 3.6&ndash;7.0]) percent predicted and BMI (0.26 [95% CI: 0.09&ndash;0.43]). Mean FEV1 of Australian patients diagnosed after newborn screening was lower by 5.2 (95% CI: 2.8&ndash;7.6) percent predicted compared with US children.

CONCLUSIONS:
Children diagnosed with CF after newborn screening benefited from better lung function and BMI than those diagnosed clinically. The benefit of newborn screening on lung function was significantly less in Australian children compared with US children. Statistical comparisons between CF registries are feasible and can contribute to benchmarking and improvements in care.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/349?rss=1">
<title>Intravenous Acetaminophen in the United States: Iatrogenic Dosing Errors</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/349?rss=1</link>
<description><![CDATA[
An intravenous formulation of acetaminophen was introduced to the United States in 2011. Experience from Europe indicates that serious dosing errors are likely to occur. Most events have involved a 10-fold dosing error in small children caused by calculating the dosage in milligrams, but then administering the solution in milliliters. The solution is 10 mg/mL; therefore, a 10-fold overdose occurs. Evaluation of overdose with the intravenous formulation is similar to oral overdose. A serum acetaminophen concentration should be drawn 4 hours after the infusion was started or as soon thereafter as possible. If the serum acetaminophen concentration plots above the treatment line on the Rumack-Matthew nomogram, treatment with acetylcysteine should be initiated. Health care providers are encouraged to contact their regional poison center (1-800-222-1222) so that dosing errors will be reported, and the experience with this new product can be accumulated.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/354?rss=1">
<title>Pediatric Analgesic Clinical Trial Designs, Measures, and Extrapolation: Report of an FDA Scientific Workshop</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/354?rss=1</link>
<description><![CDATA[
Analgesic trials pose unique scientific, ethical, and practical challenges in pediatrics. Participants in a scientific workshop sponsored by the US Food and Drug Administration developed consensus on aspects of pediatric analgesic clinical trial design. The standard parallel-placebo analgesic trial design commonly used for adults has ethical and practical difficulties in pediatrics, due to the likelihood of subjects experiencing pain for extended periods of time. Immediate-rescue designs using opioid-sparing, rather than pain scores, as a primary outcome measure have been successfully used in pediatric analgesic efficacy trials. These designs maintain some of the scientific benefits of blinding, with some ethical and practical advantages over traditional designs. Preferred outcome measures were recommended for each age group. Acute pain trials are feasible for children undergoing surgery. Pharmacodynamic responses to opioids, local anesthetics, acetaminophen, and nonsteroidal antiinflammatory drugs appear substantially mature by age 2 years. There is currently no clear evidence for analgesic efficacy of acetaminophen or nonsteroidal antiinflammatory drugs in neonates or infants younger than 3 months of age. Small sample designs, including cross-over trials and N of 1 trials, for particular pediatric chronic pain conditions and for studies of pain and irritability in pediatric palliative care should be considered. Pediatric analgesic trials can be improved by using innovative study designs and outcome measures specific for children. Multicenter consortia will help to facilitate adequately powered pediatric analgesic trials.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e356?rss=1">
<title>Urinary Proteome Analysis to Exclude Severe Vesicoureteral Reflux</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e356?rss=1</link>
<description><![CDATA[
OBJECTIVES:
High-grade vesicoureteral reflux (VUR, grade IV or V) is a risk factor for renal scarring, impaired renal function, and arterial hypertension. Voiding cystourethrography is the gold standard for detecting the severity of VUR. High-grade VUR is present in the minority of children with urinary tract infection (UTI), thus exposing the majority to invasive diagnostics that have no surgical consequence. We therefore aimed at establishing a noninvasive test to identify children with high-grade VUR.

METHODS:
In a case-control study, a specific urinary proteome pattern was established by capillary electrophoresis coupled to mass spectrometry in 18 patients with primary VUR grade IV or V, distinguishing these from 19 patients without VUR after UTI. This proteome pattern was independently validated in a blinded cohort of 17 patients with VUR grade IV or V and 19 patients without VUR.

RESULTS:
Sensitivity in detecting VUR grade IV or V in the blinded study was 88%, specificity was 79%. The test&rsquo;s accuracy was independent of age, gender, and grade of VUR in the contralateral kidney. The odds ratio of suffering from VUR grade IV or V when tested positive was 28 (95% confidence interval: 4.5 to 176.0).

CONCLUSIONS:
This noninvasive test is ready for prospective validation in large cohorts with the aim of identifying those children with UTI and hydronephrosis in need of further invasive diagnostics, such as voiding cystourethrography, thus sparing most children without pathologic urinary proteome patterns from additional diagnostics.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e364?rss=1">
<title>Bronchoscopic Findings in Children With Chronic Wet Cough</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e364?rss=1</link>
<description><![CDATA[
OBJECTIVES:
Protracted bacterial bronchitis is defined as the presence of more than 4 weeks of chronic wet cough that resolves with appropriate antibiotic therapy, in the absence of alternative diagnoses. The diagnosis of protracted bacterial bronchitis is not readily accepted within the pediatric community, however, and data on the incidence of bacterial bronchitis in children are deficient. The objective of this study was to determine the frequency of bacterial bronchitis in children with chronic wet cough and to analyze their bronchoscopic findings.

METHODS:
We performed a retrospective review of charts of children who presented with chronic wet cough, unresponsive to therapy, before referral to the pediatric pulmonary clinic.

RESULTS:
A total of 197 charts and bronchoscopy reports were analyzed. Of 109 children who were 0 to 3 years of age, 33 (30.3%) had laryngomalacia and/or tracheomalacia. The bronchoscopy showed purulent bronchitis in 56% (110) cases and nonpurulent bronchitis in 44% (87). The bronchoalveolar lavage bacterial cultures were positive in 46% (91) of the children and showed nontypable Haemophilus influenzae (49%), Streptococcus pneumoniae (20%), Moraxella catarrhalis (17%), Staphylococcus aureus (12%), and Klebsiella pneumoniae in 1 patient. The 2 analysis demonstrated that positive bacterial cultures occurred more frequently in children with purulent bronchitis (74, 69.8%) than in children with nonpurulent bronchitis (19, 19.8%) (P &lt; .001).

CONCLUSIONS:
Children who present with chronic wet cough are often found to have evidence of purulent bronchitis on bronchoscopy. This finding is often indicative of a bacterial lower airway infection in these children.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/full/129/2/365?rss=1">
<title>Newborn Dried Blood Spot Screening: Residual Specimen Storage Issues</title>
<link>http://pediatrics.aappublications.org/cgi/content/full/129/2/365?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e370?rss=1">
<title>Association of Center Volume With Mortality and Complications in Pediatric Heart Surgery</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e370?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Previous analyses have suggested center volume is associated with outcome in children undergoing heart surgery. However, data are limited regarding potential mediating factors, including the relationship of center volume with postoperative complications and mortality in those who suffer a complication. We examined this association in a large multicenter cohort.

METHODS:
Children 0 to 18 years undergoing heart surgery at centers participating in the Society of Thoracic Surgeons Congenital Heart Surgery Database (2006&ndash;2009) were included. In multivariable analysis, we evaluated outcomes associated with annual center volume, adjusting for patient factors and surgical risk category.

RESULTS:
A total of 35 776 patients (68 centers) were included. Overall, 40.6% of patients had &ge;1 complication, and the in-hospital mortality rate was 3.9%. The mortality rate in those patients with a complication was 9.0%. In multivariable analysis, lower center volume was significantly associated with higher in-hospital mortality. There was no association of center volume with the rate of postoperative complications, but lower center volume was significantly associated with higher mortality in those with a complication (P = .03 when volume examined as a continuous variable; odds ratio in centers with &lt;150 vs &gt;350 cases per year = 1.59 [95% confidence interval: 1.16&ndash;2.18]). This association was most prominent in the higher surgical risk categories.

CONCLUSIONS:
These data suggest that the higher mortality observed at lower volume centers in children undergoing heart surgery may be related to a higher rate of mortality in those with postoperative complications, rather than a higher rate of complications alone.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e377?rss=1">
<title>Social-Emotional Screening for Infants and Toddlers in Primary Care</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e377?rss=1</link>
<description><![CDATA[
BACKGROUND AND OBJECTIVES:
Recommendations in pediatrics call for general developmental screening of young children; however, research suggests social-emotional development, in particular, is important as an initial indicator of general well-being versus risk. We aim to describe a program designed to identify the social-emotional status of young children in the pediatric setting by using the Ages and Stages Questionnaires: Social-Emotional (ASQ:SE) as a universal screening tool, and to assess the effect of interventions by a colocated psychologist on changes in ASQ:SE scores over time.

METHODS:
In a prospective cohort design we analyzed scores on ASQ:SE surveys completed on children 6 to 36 months of age, to determine if children were at risk for problems in social-emotional development. The probability of remaining at risk over time was then compared between subjects receiving intervention by the psychologist, and those who declined intervention. Logit specifications were used in multivariate comparisons to control for a set of covariates.

RESULTS:
Three thousand one hundred and sixty-nine children were screened; 711 (22.4%) scored at or above the risk cutoff. Among the 711 at-risk children, 170 were rescreened. At the time of rescreening, those children who received intervention from the psychologist showed significant improvement on ASQ:SE scores compared with those who declined intervention (P = .01).

CONCLUSIONS:
Universal social-emotional screening in a busy pediatric practice is challenging. Significant percentages of children can be identified as being at risk for social-emotional problems, and colocation of a psychologist promotes the ability to effectively address young children&rsquo;s social-emotional development within their medical home.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/full/129/2/385?rss=1">
<title>Recommended Childhood and Adolescent Immunization Schedules--United States, 2012</title>
<link>http://pediatrics.aappublications.org/cgi/content/full/129/2/385?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e385?rss=1">
<title>Perioperative Methylprednisolone and Outcome in Neonates Undergoing Heart Surgery</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e385?rss=1</link>
<description><![CDATA[
BACKGROUND:
Recent studies have called into question the benefit of perioperative corticosteroids in children undergoing heart surgery, but have been limited by the lack of placebo control, limited power, and grouping of various steroid regimens together in analysis. We evaluated outcomes across methylprednisolone regimens versus no steroids in a large cohort of neonates.

METHODS:
Clinical data from the Society of Thoracic Surgeons Database were linked to medication data from the Pediatric Health Information Systems Database for neonates (&le;30 days) undergoing heart surgery (2004&ndash;2008) at 25 participating centers. Multivariable analysis adjusting for patient and center characteristics, surgical risk category, and within-center clustering was used to evaluate the association of methylprednisolone regimen with outcome.

RESULTS:
A total of 3180 neonates were included: 22% received methylprednisolone on both the day before and day of surgery, 12% on the day before surgery only, and 28% on the day of surgery only; 38% did not receive any perioperative steroids. In multivariable analysis, there was no significant mortality or length-of-stay benefit associated with any methylprednisolone regimen versus no steroids, and no difference in postoperative infection. In subgroup analysis by surgical-risk group, there was a significant association of methylprednisolone with infection consistent across all regimens (overall odds ratio 2.6, 95% confidence interval 1.3&ndash;5.2) in the lower-surgical-risk group.

CONCLUSIONS:
This multicenter observational analysis did not find any benefit associated with methylprednisolone in neonates undergoing heart surgery and suggested increased infection in certain subgroups. These data reinforce the need for a large randomized trial in this population.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/387?rss=1">
<title>School-Based Health Centers and Pediatric Practice</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/387?rss=1</link>
<description><![CDATA[
School-based health centers (SBHCs) have become an important method of health care delivery for the youth of our nation. Although they only represent 1 aspect of a coordinated school health program approach, SBHCs have provided access to health care services for youth confronted with age, financial, cultural, and geographic barriers. A fundamental principle of SBHCs is to create an environment of service coordination and collaboration that addresses the health needs and well-being of youth with health disparities or poor access to health care services. Some pediatricians have concerns that these centers are in conflict with the primary care provider&rsquo;s medical home. This policy provides an overview of SBHCs and some of their documented benefits, addresses the issue of potential conflict with the medical home, and provides recommendations that support the integration and coordination of SBHCs and the pediatric medical home practice.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e392?rss=1">
<title>Lead Poisoning in United States-Bound Refugee Children: Thailand-Burma Border, 2009</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e392?rss=1</link>
<description><![CDATA[
BACKGROUND:
Elevated blood lead levels lead to permanent neurocognitive sequelae in children. Resettled refugee children in the United States are considered at high risk for elevated blood lead levels, but the prevalence of and risk factors for elevated blood lead levels before resettlement have not been described.

METHODS:
Blood samples from children aged 6 months to 14 years from refugee camps in Thailand were tested for lead and hemoglobin. Sixty-seven children with elevated blood lead levels (venous &ge;10 &micro;g/dL) or undetectable (capillary &lt;3.3 &micro;g/dL) blood lead levels participated in a case-control study.

RESULTS:
Of 642 children, 33 (5.1%) had elevated blood lead levels. Children aged &lt;2 years had the highest prevalence (14.5%). Among children aged &lt;2 years included in a case-control study, elevated blood lead levels risk factors included hemoglobin &lt;10 g/dL, exposure to car batteries, and taking traditional medicines.

CONCLUSIONS:
The prevalence of elevated blood lead levels among tested US-bound Burmese refugee children was higher than the current US prevalence, and was especially high among children &lt;2 years old. Refugee children may arrive in the United States with elevated blood lead levels. A population-specific understanding of preexisting lead exposures can enhance postarrival lead-poisoning prevention efforts, based on Centers for Disease Control and Prevention recommendations for resettled refugee children, and can lead to remediation efforts overseas.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/394?rss=1">
<title>Patient- and Family-Centered Care and the Pediatrician&#x27;s Role</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/394?rss=1</link>
<description><![CDATA[
Drawing on several decades of work with families, pediatricians, other health care professionals, and policy makers, the American Academy of Pediatrics provides a definition of patient- and family-centered care. In pediatrics, patient- and family-centered care is based on the understanding that the family is the child&rsquo;s primary source of strength and support. Further, this approach to care recognizes that the perspectives and information provided by families, children, and young adults are essential components of high-quality clinical decision-making, and that patients and family are integral partners with the health care team. This policy statement outlines the core principles of patient- and family-centered care, summarizes some of the recent literature linking patient- and family-centered care to improved health outcomes, and lists various other benefits to be expected when engaging in patient- and family-centered pediatric practice. The statement concludes with specific recommendations for how pediatricians can integrate patient- and family-centered care in hospitals, clinics, and community settings, and in broader systems of care, as well.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e414?rss=1">
<title>Fetal and Maternal Candidate Single Nucleotide Polymorphism Associations With Cerebral Palsy: A Case-Control Study</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e414?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Previous studies have suggested associations between certain genetic variants and susceptibility to cerebral palsy (CP). This study was designed to assess established and novel maternal and child genetic and epidemiologic risk factors for CP along with their interactions.

METHODS:
DNA from 587 case and 1154 control mother-child pairs was analyzed. A panel of 35 candidate single nucleotide polymorphisms (SNPs) were examined and included SNPs in genes associated with (1) thrombophilia, (2) inflammation, and (3) risk factors for CP (eg, preterm birth). Comparisons were specified a priori and made by using a 2 test.

RESULTS:
There were 40 fetal and 28 maternal associations with CP when analyzed by CP subtype, gestational age, genotypes of apolipoprotein E, and haplotypes of mannose-binding-lectin. After Bonferroni correction for multiple testing, no fetal or maternal candidate SNP was associated with CP or its subtypes. Only fetal carriage of prothrombin gene mutation remained marginally associated with hemiplegia in term infants born to mothers with a reported infection during pregnancy. Odds ratio directions of fetal SNP associations were compared with previously reported studies and confirmed no trend toward association.

CONCLUSIONS:
Except for the prothrombin gene mutation, individual maternal and fetal SNPs in our candidate panel were not found to be associated with CP outcome. Past reported SNP associations with CP were not confirmed, possibly reflecting type I error from small numbers and multiple testing in the original reports.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e424?rss=1">
<title>Pertussis Pseudo-outbreak Linked to Specimens Contaminated by Bordetella pertussis DNA From Clinic Surfaces</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e424?rss=1</link>
<description><![CDATA[
BACKGROUND AND OBJECTIVES:
We investigated a pertussis outbreak characterized by atypical cases, confirmed by polymerase chain reaction (PCR) alone at a single laboratory, which persisted despite high vaccine coverage and routine control measures. We aimed to determine whether Bordetella pertussis was the causative agent and advise on control interventions.

METHODS:
We conducted case ascertainment, confirmatory testing for pertussis and other pathogens, and an assessment for possible sources of specimen contamination, including a survey of clinic practices, sampling clinics for B pertussis DNA, and review of laboratory quality indicators.

RESULTS:
Between November 28, 2008, and September 4, 2009, 125 cases were reported, of which 92 (74%) were PCR positive. Cases occurring after April 2009 (n = 79; 63%) had fewer classic pertussis symptoms (63% vs 98%; P &lt; .01), smaller amounts of B pertussis DNA (mean PCR cycle threshold value: 40.9 vs 33.1; P &lt; .01), and a greater proportion of PCR-positive results (34% vs 6%; P &lt; .01). Cultures and serology for B pertussis were negative. Other common respiratory pathogens were detected. We identified factors that likely resulted in specimen contamination at the point of collection: environmentally present B pertussis DNA in clinics from vaccine, clinic standard specimen collection practices, use of liquid transport medium, and lack of clinically relevant PCR cutoffs.

CONCLUSIONS:
A summer pertussis pseudo-outbreak, multifactorial in cause, likely occurred. Recommendations beyond standard practice were made to providers on specimen collection and environmental cleaning, and to laboratories on standardizing PCR protocols and reporting results, to minimize false-positive results from contaminated clinical specimens.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e431?rss=1">
<title>Genetic Causes of Macroglossia: Diagnostic Approach</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e431?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Evaluate the contribution of standard diagnostic tests for macroglossia when clinical features are not suggestive of Beckwith-Wiedemann syndrome (BWS).

METHODS:
A retrospective analysis of data from clinical, laboratory, and imaging information from children with macroglossia seen at Cincinnati Children&rsquo;s Hospital Medical Center between 1997 and 2010 was performed.

RESULTS:
One hundred thirty-five children with macroglossia were identified. Macroglossia was the main reason for consultation in 84 children. Patients were classified on initial examination as isolated macroglossia (n = 24), provisional BWS (n = 36), and syndromic (n = 24). A final diagnosis was reached in 74 patients, and in 10 patients the reason for macroglossia remained undetermined. Among the elucidated cases, BWS was the most common cause of macroglossia (39/84). Six of the 24 patients in the isolated macroglossia group had an abnormal molecular test for BWS (P = .006). Thirteen diagnostic conditions were confirmed in this study, and 42% of the population had a specific diagnosis that was not BWS (35/84).

CONCLUSIONS:
These results can be used to improve our strategy in the evaluation of macroglossia. Distinction between isolated macroglossia and BWS may be difficult when only taking into account clinical features. These findings suggest that all patients with apparently isolated macroglossia have at least initial evaluation with abdominal ultrasounds and molecular studies for BWS before a final diagnosis is given. BWS was the most common cause of macroglossia even in the absence of additional clinical findings.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e438?rss=1">
<title>Calculation of Expected Body Weight in Adolescents With Eating Disorders</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e438?rss=1</link>
<description><![CDATA[
OBJECTIVE:
To examine the agreement between three methods to calculate expected body weight (EBW) for adolescents with eating disorders: (1) BMI percentile, (2) McLaren, and (3) Moore methods.

METHODS:
The authors conducted a cross-sectional analysis of baseline information from adolescents seeking treatment of disordered eating at The University of Chicago. Adolescents (N = 373) aged 12 to 18 years (mean = 15.84, SD = 1.72), with anorexia nervosa (n = 130), bulimia nervosa (n = 59), or eating disorder not otherwise specified (n = 184). Concurrence between the BMI percentile, McLaren, and Moore methods was assessed for agreement above or below arbitrary cut points used in relation to hospitalization (75%), diagnosis (85%), and healthy weight (100%). Patterns of absolute discrepancies were examined by height, age, gender, and menstrual status. Limitations to some of these methods allowed comparison between all 3 methods in only 204 participants.

RESULTS:
Moderate agreement was seen between the 3 methods ( values, 0.48&ndash;0.74), with pairwise total classification accuracy at each cut point ranging from 84% to 98%. The most discrepant calculations were observed among the tallest (&gt;75th percentile) and shortest (&lt;20th percentile) cases and older ages (&gt;16 years). Many of the most discrepant cases fell above and below 85% EBW when comparing the BMI percentile and Moore methods, indicating disagreement on possible diagnosis of anorexia nervosa.

CONCLUSIONS:
These methods largely agree on percent EBW in terms of clinically significant cut points. However, the McLaren and Moore methods present with limitations, and a commonly agreed-upon method for EBW calculation such as the BMI percentile method is recommended for clinical and research purposes.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e447?rss=1">
<title>Intrapartum Temperature Elevation, Epidural Use, and Adverse Outcome in Term Infants</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e447?rss=1</link>
<description><![CDATA[
OBJECTIVES:
 To examine the association of intrapartum temperature elevation with adverse neonatal outcome among low-risk women receiving epidural analgesia and evaluate the association of epidural with adverse neonatal outcome without temperature elevation.

METHODS:
We studied all low-risk nulliparous women with singleton pregnancies &ge;37 weeks delivering at our hospital during 2000, excluding pregnancies where infants had documented sepsis, meningitis, or a major congenital anomaly. Neonatal outcomes were compared between women receiving (n = 1538) and not receiving epidural analgesia (n = 363) in the absence of intrapartum temperature elevation (&le;99.5&deg;F) and according to the level of intrapartum temperature elevation within the group receiving epidural (n = 2784). Logistic regression was used to evaluate neonatal outcome while controlling for confounders.

RESULTS:
Maternal temperature &gt;100.4&deg;F developed during labor in 19.2% (535/2784) of women receiving epidural compared with 2.4% (10/425) not receiving epidural. In the absence of intrapartum temperature elevation (&le;99.5&deg;F), no significant differences were observed in adverse neonatal outcomes between women receiving and not receiving epidural. Among women receiving epidural, a significant linear trend was observed between maximum maternal temperature and all neonatal outcomes examined including hypotonia, assisted ventilation, 1- and 5-min Apgar scores &lt;7, and early-onset seizures. In regression analyses, infants born to women with fever &gt;101&deg;F had a two- to sixfold increased risk of all adverse outcomes examined.

CONCLUSIONS:
The proportion of infants experiencing adverse outcomes increased with the degree of epidural-related maternal temperature elevation. Epidural use without temperature elevation was not associated with any of the adverse outcomes we studied.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e455?rss=1">
<title>Genetic and Environmental Components of Neonatal Weight Gain in Preterm Infants</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e455?rss=1</link>
<description><![CDATA[
BACKGROUND AND OBJECTIVES:
Postnatal nutrition and subsequent weight gain or failure in the neonatal period are likely regulated by both the environment and the genetic background. With the goal of estimating the variability of postnatal weight gain due to genes and environment, comparison between monozygotic (ie, genetically identical) and dizygotic (genetically similar as 2 siblings) twins can be performed.

METHODS:
This study selected a very homogenous set of monozygotic and dizygotic twins who met the following inclusion criteria: gestational age between 30 and 36 weeks, birth weight between 1250 and 2200 g, and length of stay &gt;12 days. Opposite-gender pairs and pairs that differed &gt;20% in terms of birth weight were excluded from this analysis. The outcome measure of this study was the daily weight gain expressed in grams per kilogram per day during the period between day of birth and day of discharge. The average difference between members of a pair was computed in the 2 groups of twins, and heritability was estimated.

RESULTS:
The within-pair differences of the outcome measure were lower for monozygotic twins than for dizygotic twins, suggesting a strong genetic component. The total variance of the phenotype under study is explained by 2 sources of variation, additive genetic (87% [95% confidence interval: 67% to 94%]) and unique environment (13% [95% confidence interval: 6% to 33%]) components.

CONCLUSIONS:
This high heritability estimate could suggest using this set of criteria to identify genes that regulate postnatal weight gain or failure.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e460?rss=1">
<title>An Integrated Scientific Framework for Child Survival and Early Childhood Development</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e460?rss=1</link>
<description><![CDATA[
Building a strong foundation for healthy development in the early years of life is a prerequisite for individual well-being, economic productivity, and harmonious societies around the world. Growing scientific evidence also demonstrates that social and physical environments that threaten human development (because of scarcity, stress, or instability) can lead to short-term physiologic and psychological adjustments that are necessary for immediate survival and adaptation, but which may come at a significant cost to long-term outcomes in learning, behavior, health, and longevity. Generally speaking, ministries of health prioritize child survival and physical well-being, ministries of education focus on schooling, ministries of finance promote economic development, and ministries of welfare address breakdowns across multiple domains of function. Advances in the biological and social sciences offer a unifying framework for generating significant societal benefits by catalyzing greater synergy across these policy sectors. This synergy could inform more effective and efficient investments both to increase the survival of children born under adverse circumstances and to improve life outcomes for those who live beyond the early childhood period yet face high risks for diminished life prospects.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e473?rss=1">
<title>Pediatric Self-management: A Framework for Research, Practice, and Policy</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e473?rss=1</link>
<description><![CDATA[
Self-management of chronic pediatric conditions is a formidable challenge for patients, families, and clinicians, with research demonstrating a high prevalence of poor self-management and nonadherence across pediatric conditions. Nevertheless, effective self-management is necessary to maximize treatment efficacy and clinical outcomes and to reduce unnecessary health care utilization and costs. However, this complex behavior is poorly understood as a result of insufficient definitions, reliance on condition-specific and/or adult models of self-management, failure to consider the multitude of factors that influence patient self-management behavior, and lack of synthesis of research, clinical practice, and policy implications. To address this need, we present a comprehensive conceptual model of pediatric self-management that articulates the individual, family, community, and health care system level influences that impact self-management behavior through cognitive, emotional, and social processes. This model further describes the relationship among self-management, adherence, and outcomes at both the patient and system level. Implications for research, clinical practice, and health care policy concerning pediatric chronic care are emphasized with a particular focus on modifiable influences, evidence-based targets for intervention, and the role of clinicians in the provision of self-management support. We anticipate that this unified conceptual approach will equip stakeholders in pediatric health care to (1) develop evidence-based interventions to improve self-management, (2) design programs aimed at preventing the development of poor self-management behaviors, and (3) inform health care policy that will ultimately improve the health and psychosocial outcomes of children with chronic conditions.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e486?rss=1">
<title>The Sudden Unexpected Infant Death Case Registry: A Method to Improve Surveillance</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e486?rss=1</link>
<description><![CDATA[
This article describes a multistate population-based surveillance system for monitoring sudden unexpected infant deaths (SUIDs) known as the SUID Case Registry pilot program. The pilot program represents collaboration between the Centers for Disease Control and Prevention and the National Center for Child Death Review (NCCDR), which is funded by the Health Resources and Services Administration. The SUID Case Registry builds on existing child death review system activities and protocols. The objectives of the SUID Case Registry are to collect accurate and consistent population-based data about the circumstances and events associated with SUID cases, to improve the completeness and quality of SUID case investigations, and to use a decision-making algorithm with standardized definitions to categorize SUID cases. States who participate in the pilot program commit to review all SUID cases in their state by using their multidisciplinary state and local child death review teams. These teams request and review data from death scene investigators, medical examiners and coroners, law enforcement, social services, pediatric and obstetric providers, and public health per usual, but as part of the pilot program, supplement their SUID case reviews by discussing additional medical, environmental, and behavioral factors, and entering this data using the NCCDR Web-based Case Reporting System. This new surveillance system aims to improve knowledge of factors surrounding SUID events and improve investigation practices. The surveillance system will allow researchers and program planners to create prevention strategies and interventions, ultimately reducing SUIDs and injury-related infant deaths.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/full/129/2/e494?rss=1">
<title>Long-term Intellectual Outcome of Traumatic Brain Injury in Children: Limits to Neuroplasticity of the Young Brain?</title>
<link>http://pediatrics.aappublications.org/cgi/content/full/129/2/e494?rss=1</link>
<description><![CDATA[ ]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e496?rss=1">
<title>Improving the Quality of Immunization Delivery to an At-Risk Population: A Comprehensive Approach</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e496?rss=1</link>
<description><![CDATA[
OBJECTIVE:
Immunization quality improvement (QI) interventions are rarely tested as multicomponent interventions within the context of a theoretical framework proven to improve outcomes. Our goal was to study a comprehensive QI program to increase immunization rates for underserved children that relied on recommendations from the Centers for Disease Control and Prevention&rsquo;s Task Force on Community Preventive Services and the framework of the Chronic Care Model.

METHODS:
QI activities occurred from September 2007 to May 2008 at 6 health centers serving a low-income, minority population in Washington, DC. Interventions included family reminders, education, expanding immunization access, reminders and feedback for providers, and coordination of activities with community stakeholders. We determined project effectiveness in improving the 4:3:1:3:3:1:3 vaccination series (4 diphtheria-tetanus-pertussis vaccines, 3 poliovirus vaccines, 1 measles-mumps-rubella vaccine, 3 Haemophilus influenzae type b vaccines, 3 hepatitis B vaccines, 1 varicella vaccine, and three 7-valent pneumococcal conjugate vaccines) compliance.

RESULTS:
We found a 16% increase in immunization rates overall and a 14% increase in on-time immunization by 24 months of age. Improvement was achieved at all 6 health centers and maintained beyond 18 months.

CONCLUSION:
We were able to implement a comprehensive immunization QI program that was sustainable over time.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e504?rss=1">
<title>Enhancing Accurate Identification of Food Insecurity Using Quality-Improvement Techniques</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e504?rss=1</link>
<description><![CDATA[
BACKGROUND AND OBJECTIVES:
Infants who live in households experiencing food insecurity are at risk for negative health and developmental outcomes. Despite large numbers of households within our population experiencing food insecurity, identification of household food insecurity during standard clinical care is rare. The objective of this study was to use quality-improvement methods to increase identification of household food insecurity by the second-year pediatric residents working in the Pediatric Primary Care Center from 1.9% to 15.0% within 6 months. A secondary aim was to increase the proportion of second-year pediatric residents identifying food insecurity.

METHODS:
A team was formed to identify key drivers thought to be critical to the process of identifying food insecurity during well-child care. This project addressed 5 key drivers and tested interventions based on these drivers over a 6-month period at a hospital-based primary care site that serves ~15 000 children from underserved neighborhoods. Tests included implementing an evidence-based electronic screen for food insecurity, educational interventions to improve understanding of food insecurity, empowerment exercises targeting clinicians and families, and gaining buy-in and support from ancillary personnel.

RESULTS:
Implementation of these changes led to an increase in the identification rate of household food insecurity from 1.9% to 11.2% over the 6 months (P &lt; .01). The proportion of residents identifying food insecurity increased from 37.5% to 91.9% (P &lt; .01).

CONCLUSIONS:
Application of quality-improvement methods in a primary care clinic increased ability to effectively screen and positively identify households with food insecurity in this population.

]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e511?rss=1">
<title>Successful Treatment of Type 1 Diabetes and Seizures With Combined Ketogenic Diet and Insulin</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e511?rss=1</link>
<description><![CDATA[
Diabetic ketoacidosis (DKA) is a life-threatening condition and a major cause of morbidity and mortality in children with type 1 diabetes mellitus. The deficiency of insulin leads to metabolic decompensation, causing hyperglycemia and ketosis that resolves with the administration of insulin and fluids. However, an induced state of ketosis is the basis for the success of the ketogenic diet (KD), which is an effective therapy for children with intractable epilepsy. We report the case of a 2-year-old girl who presented to the emergency department with 1-week history of decreased activity, polyuria, and decreased oral intake. Her past medical history was remarkable for epilepsy, for which she was started on the KD with a significant improvement. Her laboratory evaluation was compatible with DKA, and fluids and insulin were given until correction. Because of concerns regarding recurrence of her seizures, the KD was resumed along with the simultaneous use of insulin glargine and insulin aspart. Urine ketones were kept in the moderate range to keep the effect of ketosis on seizure control. Under this combined therapy, the patient remained seizure-free with no new episodes of DKA.
]]></description>
</item>

<item rdf:about="http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e515?rss=1">
<title>Malrotation of the Intestine and Chronic Volvulus as a Cause of Protein-Losing Enteropathy in Infancy</title>
<link>http://pediatrics.aappublications.org/cgi/content/abstract/129/2/e515?rss=1</link>
<description><![CDATA[
Protein-losing enteropathy in children is caused by intestinal metabolic, inflammatory, or infectious processes, or by lymphatic obstruction (intestinal lymphangiectasia). In this report, a 17-month-old child is presented with protein-losing enteropathy due to intestinal malrotation and chronic midgut volvulus causing lymphatic obstruction and spillage of lymph in the int
